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REGULATION OF THE ESCRT FUNCTION OF ALIX 
 
Sheng Sun, M.S. 
 
Advisory Professor: Jian Kuang, Ph.D. 
 
The ESCRT (endosomal sorting complex required for transport) is an 
evolutionary conserved membrane remodeling machinery that performs membrane 
invagination and abscission. ALIX is a widely expressed adaptor protein that is critically 
involved in three classical ESCRT-mediated processes, including MVB (multivesicular 
body) sorting, cytokinetic abscission and retroviral budding. Previous studies have 
demonstrated that ALIX involvement in these ESCRT-mediated processes requires 
ALIX interaction with the ESCRT-III component CHMP4 as well as a cargo protein. 
However, the native form of ALIX contains a default intramolecular interaction between 
N-terminal Bro1 domain and C-terminal PRD (proline-rich domain), leading to a closed 
conformation of ALIX that cannot interact with CHMP4. This predicts that ALIX 
involvement in ESCRT-mediated processes requires an activation step that relieves the 
intramolecular interaction of ALIX.  
The objective of my dissertation research is to identify the regulatory 
mechanisms that activate the ESCRT function of ALIX in the three classical ESCRT-
mediated processes. Whether ALIX is critically involved in MVB sorting of ubiquitinated 
receptors has been controversial. By examining the effects of ALIX on the level of 
activated EGFR in the lumen of MVB and the level of EGF-induced phosphorylated 
ERK1/2, which is the downstream signaling of activated EGFR, I showed that CHMP4-
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bound ALIX dimer plays an essential role in MVB sorting and silencing of activated 
EGFR. However, MVB sorting of activated EGFR is not required for its degradation. My 
studies thus identify ALIX as an important regulator for signaling output of the activated 
EGFR. I further demonstrated that ALG-2 (apoptosis-linked gene 2 product) is 
responsible for generating ALIX in open conformation that supports MVB sorting and 
timely silencing of activated EGFR. My studies thus identify ALG-2 as a potential 
negative regulator for the signaling transduction of activated EGFR and provide a new 
understanding for the role of ALG-2 in apoptotic induction.  
While ALG-2 is important for ALIX-mediated MVB sorting, I found that ALG-2 is 
not important for ALIX-mediated cytokinetic abscission or retroviral budding. Thus, I 
further identified mechanism that activates ALIX in these two ESCRT-mediated 
processes. By studying mitotic phosphorylation of ALIX, I found that phosphorylation at 
S718 and S721 residues in the PRD domain of ALIX relieves the intramolecular 
interaction of ALIX. This mechanism is required for generating ALIX in open 
conformation that supports cytokinetic abscission and retroviral budding. These 
findings provide a new understanding for the regulation of cytokinesis and retroviral 
budding and may provide new strategies for inhibiting cell division and retroviral 
budding.  
In summary, my dissertation studies have identified two regulatory mechanisms 
that relieve the intramolecular interaction of ALIX in the three classical ESCRT-
mediated membrane remodeling processes. These studies provide insights into the 
regulation of ESCRT-mediated membrane remodeling processes and suggest that 
ALIX may be a potential target for anti-cancer and anti-viral therapy. 
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Chapter 1: Introduction 
 
1.1. Endolysosomal trafficking of cell surface receptors 
Ligand binding to cell surface receptors induces the activation of receptors, 
which then induces the internalization of these activated receptors in membrane-
bounded vesicles through a plasma membrane invagination process, called 
endocytosis (Marsh and McMahon, 1999). These receptor-containing vesicles are then 
fused with early endosome.   
From early endosome, there are three fates for these receptors. First, receptors 
can recycle back to cell surface. During the recycling process, these receptors still have 
signaling function, activating the downstream signaling pathways. Second, receptors 
can stay on the membrane of early endosome. This portion of receptors also keeps 
their signaling function. The third fate is to be sorted into the lumen of early endosome 
through an endosome membrane invagination and abscission process, called MVB 
(multivesicular body) sorting.  
MVB sorting terminates the signaling function of the activated receptors and it is 
a very quick process, happening in ~30 min after ligand binding. Although the receptors 
both on the membrane and in the lumen of early endosome will be trafficked to late 
endosome and then lysosome for degradation, receptors staying on the endosome 
membrane will keep on sending signals to the downstream pathways during the 
trafficking process, which takes several hours. Thus, if activated receptors are not 
properly sorted into endosome through MVB sorting, the duration of the downstream 
signaling will be prolonged and it may lead to uncontrolled cell proliferation. Thus, MVB 
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sorting is an important process that functions as a negative regulator of activated 
receptors. 
The whole process initiating from endocytosis of the activated receptors until to 
lysosome-dependent degradation of these receptors is called endolysosomal trafficking 
(Feyder et al., 2015; Goh and Sorkin, 2013; Mellman, 1996; Scott et al., 2014; Sorkin 
and Goh, 2009; Wegner et al., 2011) (Fig. 1).  
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Figure 1. Endolysosomal trafficking of cell surface receptors. Endolysosomal 
trafficking initiates from the receptor activation-induced endocytosis.  The endocytosed 
receptors either recycle back to cell surface (1), stay on the membrane of early 
endosome (2) or are sorted into the lumen of early endosome (MVB sorting) (3). Then, 
MVB will be fused with lysosome to deliver receptors for lysosome-dependent 
degradation.  
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1.2. Discovery of ESCRT and its MVB sorting function 
MVB sorting is in the opposite topology of endocytosis. While endocytosis 
involves budding of vesicles into cytoplasm, MVB sorting involves budding of vesicles 
away from cytoplasm (Fig. 1). Thus, the mechanism underlining endocytosis does not 
apply to MVB sorting. Therefore, it is important to have a powerful model system to 
study the mechanism underlining MVB sorting. The researchers found that yeast 
Saccharomyces cerevisiae is the most powerful model system for studying MVB sorting 
for several reasons. First, MVB sorting pathway is conserved from yeast to human. In 
yeast cells, membrane proteins also go through MVB sorting to vacuole, the 
intracellular organelle sharing functional characteristics with mammalian lysosome 
(Banta et al., 1988; Henne et al., 2013). Second, it is convenient to perform genetic 
screen in yeast to search for the genes, whose products are involved in MVB sorting. 
Plasmids with no gene-specific sequences can be delivered into yeast cells and these 
sequences can integrate randomly throughout the genome and randomly disrupt the 
genes to generate various mutant yeast strains. Through observing the expected 
phenotypes, which are the abnormal morphology of endosome and the defective 
sorting of GFP-labelled vacuole enzyme, carboxypeptidase S (CPS), the researchers 
could identify the genes that are required for normal MVB sorting pathway (Banta et al., 
1988; Forsburg, 2001). Third, the phenotypes induced by defective MVB sorting can be 
easily observed under microscope (Banta et al., 1988; Raymond et al., 1992; Robinson 
et al., 1988).   
By using yeast as the model system, Emr and Stevens groups found that loss of 
several genes in yeast led to exaggerated endosome-like compartment (the class E 
compartment) and defective sorting of vacuole enzyme. They named this type of genes, 
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which is required for MVB sorting, as Class E Vps (vacuolar protein sorting) (Banta et 
al., 1988; Raymond et al., 1992; Robinson et al., 1988).   
Further biochemical and cellular studies from Emr group found that products of 
Class E genes Vps23, Vps28, and Vps37 form a protein complex, which binds the 
ubiquitinated sorting receptors in yeast. They named this protein complex as ESCRT-I 
(endosomal sorting complex required for transport-I) (Katzmann et al., 2001). Then, 
they found that products of Class E genes Vps2, Vps20, Vps24, and Snf7 form a 
protein complex, which have direct effects on MVB sorting activity in yeast. They 
named this protein complex as ESCRT-III (Babst et al., 2002a). They also found that 
products of Class E genes Vps22, Vps25, and Vps36 form a protein complex, which 
also binds ubiquitinated sorting proteins, associates with endosome membrane and 
interacts with ESCRT-III and promotes its assembly. They named this protein complex 
as ESCRT-II (Babst et al., 2002b). 
Further studies in mammalian cells revealed that these Class E gene products 
are conserved from yeast to human. Mammalian cells contain the orthologs of all these 
yeast Class E gene products, which also constitute ESCRT-I, II, and III (Henne et al., 
2013; Hurley, 2010) (Table 1 and Fig. 2). The studies in mammalian cells also identified 
a protein complex consisting of STAM (signal-transducing adaptor molecule) and Hrs 
(hepatocyte growth factor-regulated tyrosine kinase substrate). This protein complex, 
which was shown to bind ubiquitinated sorting receptors, associate with endosome 
membrane and is involved in MVB sorting, was named as ESCRT-0 (Table 1 and Fig. 
2). Then, the genetic screen in yeast also identified two Class E Vps genes (Hes1 and 
Vps27), whose products are orthlogs of mammalian Hrs and STAM, respectively 
(Bilodeau et al., 2002; Katzmann et al., 2003) (Table 1). 
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The essence of MVB sorting is linking receptor recognition and endosome 
membrane abscission. ESCRT machinery is anchored on the endosome membrane 
through direct interaction between ESCRTs-0/-II components and endosome 
membrane-associated PtdIns(3)P lipid. ESCRT-0, -I, and -II function as a stable hetero-
oligomers to recognize and concentrate ubiquitinated receptors through the ubiquitin-
binding motifs in the components of these three ESCRTs (Fig. 2). ESCRT-II initiates 
the sequential activation and assembly of ESCRT-III, which, in default condition, exists 
as autoinhibited monomers in the cytoplasm. The formed oligomerized ESCRT-III 
filaments localize around the neck of the budding vesicle and perform the membrane 
abscission. AAA ATPase Vps4 interacts with ESCRT-III and provides energy to 
dissemble the ESCRT-III after MVB sorting (Babst et al., 1998; Boura et al., 2012; 
Caillat et al., 2015; Henne et al., 2012; McCullough et al., 2015; Teis et al., 2008; Yang 
et al., 2015) (Fig. 2). Thus, ESCRT is evolutionary conserved membrane remolding 
machinery that execute MVB sorting pathway.   
1.3. MVB sorting-related functions of ESCRT 
Besides MVB sorting, the second identified function of ESCRT is retroviral 
budding. ESCRTs were found to be hijacked by retroviruses for their budding away 
from the host cells. Retrovirus, such as HIV-1 and EIAV (equine infectious anemia 
virus), recruits ESCRT-III to the budding site through direct interaction between 
retroviral Gag protein and ESCRT-associated protein (Beata MierzwaVotteler and 
Sundquist, 2013; Martin-Serrano and Neil, 2011; Strack et al., 2003; von Schwedler et 
al., 2003). The studies by using siRNA knockdown and rescuing experiments indicated 
that among the ESCRT-III components, only CHMP4 (charged multivesicular body 
protein 4) and CHMP2 are critically involved in HIV-1 and EIAV budding. CHMP4 
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filaments are assembled in circular arrays that bend the plasma membrane away from 
the cytoplasm. Then, CHMP4 filaments are “capped” by recruiting CHMP2 subcomplex, 
which subsequently binds and recruits Vps4 (Sandrin and Sundquist, 2013).  
The third identified function of ESCRT is cytokinetic abscission, the final step of 
cell division where daughter cells are physically separated (Carlton et al., 2008; Carlton 
and Martin-Serrano, 2007; Morita et al., 2007). The essential event in cytokinetic 
abscission is the recruitment of ESCRT-III to the midbody area and its assembly to 
oligomerized filaments, which perform the membrane abscission (Carlton et al., 2008; 
Carlton and Martin-Serrano, 2007; Morita et al., 2007). Three models have been 
proposed for how ESCRT-III filaments promote membrane abscission. One is “spiral-
ingression” model, in which ESCRT-III forms filaments at the midbody and the spiral 
filaments wind from the midbody and the end of the narrowing spirals is the abscission 
zone. Another one is “sliding spiral” model, in which ESCRT-III forms filaments at the 
midbody and the spiral filaments slide along the intracellular bridge to form an 
abscission site ∼1 μm from the midbody. The third one is “vesicle-mediated ingression” 
model, in which intracellular vesicles derived from recycling endosomes form the 
abscission zone by narrowing the intercellular bridge through fusion with the plasma 
membrane (Henne et al., 2013).  
MVB sorting, cytokinetic abscission and retroviral budding are three best-
characterized ESCRT-mediated processes with the same topology. Therefore, these 
three processes are called classical ESCRT-mediated processes (Fig. 3). Besides 
these three classical ESCRT-mediated processes, multiple novel functions of ESCRT 
have been reported recently, including exosome biogenesis (Baietti et al., 2012), 
plasma membrane wound repair (Jimenez et al., 2014; Scheffer et al., 2014), 
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autophagy (Murrow et al., 2015) and nuclear envelope reformation (Olmos et al., 2015; 
Vietri et al., 2015). These novel functions reveal remarkably widespread roles of 
ESCRTs in cellular processes.  
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Table 1. ESCRT proteins in yeast and mammalian cells 
 Yeast Human 
ESCRT-0 Vps27 Hrs 
 Hes1 STAM1/2 
ESCRT-I Vps23 TSG101 
 Vps28 Vps28 
 Vps37 Vps37 
 Mvb12 hMvb12 
ESCRT-II Vps36 EAP45 
 Vps22 EAP30 
 Vps25 EAP20 
ESCRT-III Vps20 CHMP6 
 Snf7 CHMP4 
 Vps24 CHMP3 
 Vps2 CHMP2 
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Figure 2. Illustration of ESCRT machinery in mammalian cells.  The subunits of 
each ESCRT complex and Vps4 are shown. ESCRT-0 component STAM (signal-
transducing adaptor molecule), ESCRT-I component TSG101 (tumor susceptibility 
gene 101) and ESCRT-II component EAP45 contain ubiquitin binding motifs that 
recognize ubiquitinated cargo proteins. 
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Figure 3. Three classical ESCRT-mediated processes. MVB sorting of internalized 
receptors, cytokinetic abscission and retroviral budding are three classical ESCRT-
mediated processes, having the same topology (budding away from cytoplasm) and 
sharing the mechanism for membrane invagination and abscission (requiring ESCRTs). 
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1.4. ESCRT-associated protein: ALIX 
Through the genetic screen of the mutant class E Vps genes leading to defective 
MVB sorting of GFP-Labelled CPS in yeast, Emr and his colleagues identified that 
product of BRO1 (BCK1-like Resistance to Osmotic shock) gene is required for normal 
MVB sorting pathway (Odorizzi et al., 2003). BRO1 protein consists of three domains: 
an N-terminal Bro1 domain, a middle V letter-shape domain and a C-terminal proline-
rich domain (PRD) (Odorizzi, 2006; Odorizzi et al., 2003). BRO1 binds ubiquitinated 
receptors through its ubiquitin-binding motif in the V domain and this ubiquitin-binding 
activity is required for BRO1 to support MVB sorting pathway (Pashkova et al., 2013). 
BRO1 also interacts with ESCRT-III component Snf7 through its Bro1 domain and 
regulates the assembly and the membrane abscission capability of ESCRT-III filament 
(Odorizzi et al., 2003; Wemmer et al., 2011). Thus, BRO1 functions to link the receptor 
recognition and ESCRT-III mediated membrane abscission. 
ALIX (ALG-2 interacting protein X) (Missotten et al., 1999), also termed AIP1 
(Vito et al., 1999) was initially identified and cloned by two independent studies 
searching for partner proteins of ALG-2 (apoptosis-linked gene 2 product) in mouse. 
Structural studies of ALIX revealed that ALIX and BRO1 share structural organization. 
ALIX also consists of three domains: an N-terminal Bro1 domain, a middle V letter-
shaped domain and a C-terminal PRD (Fisher et al., 2007). The Bro1 domain of ALIX 
contains a binding site (hydrophobic Patch 1) for ESCRT-III component CHMP4 and a 
docking site (hydrophobic Patch 2) for Src (Kim et al., 2005; McCullough et al., 2008). 
The V domain of ALIX contains the ubiquitin-binding motifs for preferably interacting 
with Lys-63 polyubiquitin chain (Dowlatshahi et al., 2012; Keren-Kaplan et al., 2013) 
and a hydrophobic three dimensional interaction site (F676 pocket) for proteins 
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containing YPX(n)L motif, such as retroviral Gag proteins (Lee et al., 2007; Zhai et al., 
2008), syntenin (Baietti et al., 2012) and PAR1 (protease activated receptor 1) (Dores 
et al., 2012a; Dores et al., 2012b). The PRD of ALIX contains two linear docking sites 
(residues 717-720 and 852-855) for ESCRT-I component TSG101, an ALIX 
multimerization sequence and an ALG-2 binding site (residues 801-812) (Carlton et al., 
2008) (Fig. 4).  
As the ESCRT-associated protein, ALIX was first found to be involved in 
ESCRT-mediated retroviral budding, during which retroviral Gag proteins directly 
interact with the F676 pocket in the V domain of ALIX and through this interaction, 
retrovirus hijacks ESCRT-III of host cells to plasma membrane for membrane 
abscission (Strack et al., 2003; von Schwedler et al., 2003). Then, ALIX was 
demonstrated to be essential for ESCRT-mediated cytokinetic abscission, during which 
ALIX is recruited to the midbody through direct interaction with CEP55 (entrosomal 
protein of 55 kDa), which is recruited to midbody during cytokinesis. The midbody-
localized ALIX recruits CHMP4 to the midbody area and promotes the assembly of 
ESCRT-III filaments, which perform the membrane abscission at the midbody area 
(Carlton et al., 2008; Carlton and Martin-Serrano, 2007; Morita et al., 2007).  
As the mammalian ortholog of yeast BRO1, ALIX was predicted to be involved in 
MVB sorting of ubiquitinated receptors in mammalian cells, just as BRO1 does in yeast 
(Pashkova et al., 2013). However, by using EGFR as the model molecule, multiple 
previous studies generated negative results by showing that knockdown of ALIX 
produced no or only a minor inhibitory effect on degradation of activated EGFR in HeLa 
cells (Bowers et al., 2006; Cabezas et al., 2005; Doyotte et al., 2008; Schmidt et al., 
2004). Since MVB sorting is generally thought to be required for lysosome-dependent 
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degradation of activated EGFR, these results led to a widely held notion that ALIX does 
not play a critical role in ESCRT-mediated MVB sorting of ubiquitinated membrane 
receptor in mammalian cells. However, two independent studies reported that inhibition 
of MVB sorting of activated EGFR by treating cells with PI3-kinase inhibitor wortmannin 
or by knocking down annexin 1 only generated a minor inhibitory effect on degradation 
of activated EGFR (Futter et al., 2001; White et al., 2006), indicating that MVB sorting 
may not be necessary for lysosome-dependent degradation of ubiquitinated receptors 
in mammalian cells. Thus, the lysosome-dependent degradation of activated EGFR 
may not be the reliable indication for MVB sorting of activated EGFR in mammalian 
cells. Moreover, both mammalian ALIX and yeast BRO1 contain ubiquitin binding 
motifs that interact with Lys63 poly-ubiquitin chain (Dowlatshahi et al., 2012; Pashkova 
et al., 2013), indicating that ALIX is probably able to recognize and interact with 
ubiquitinated receptors, such as activated EGFR, which requires Lys63 
polyubiquitination for its lysosome-dependent degradation (Huang et al., 2013). 
Therefore, whether ALIX is critically involved in MVB sorting of activated EGFR has 
been controversial. 
Since MVB sorting of activated receptor tyrosine kinases, such as EGFR, is 
involved in timely terminating the signaling function of these receptors (~30 min) before 
these receptors are delivered to lysosome for degradation (several hours), thus MVB 
sorting is an important regulatory mechanism that prevents uncontrolled cell 
proliferation induced by over-activation of receptor tyrosine kinases. Investigating the 
role of ALIX in MVB sorting of ubiquitinated receptors will provide great insights into the 
regulation of such an important process.  
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Figure 4. Schematic diagram depicting the domain organization of ALIX and 
BRO1. Mammalian ALIX contains 868 amino acids and yeast BRO1 contains 844 
amino acids. In ALIX, Bro1 domain binds ESCRT-III component CHMP4, V domain 
binds Lys63 poly-ubiquitinated proteins and PRD binds ESCRT-I component TSG101 
and ALG-2. In BRO1, Bro1 domain binds ESCRT-III component Snf7, which is yeast 
homolog of CHMP4 and V domain also binds Lys63 poly-ubiquitinated proteins. 
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1.5. Diverse cellular functions of ALIX 
Besides ESCRT-mediated processes, ALIX has also been reported to be 
involved in diverse cellular processes that do not need involvement of ESCRT. Studies 
from Bögler group found that ALIX interacts with focal adhesion kinase (FAK) and 
proline rich tyrosine kinase 2 (PYK-2) and through these interactions, ALIX regulates 
cell adhesion (Schmidt et al., 2003). Then, studies from our group found that ALIX 
directly interacts with F-actin and promotes actin cytoskeleton assembly. We also found 
that sub-population of ALIX can be secreted outside of the cells and the extracellular 
ALIX is involved in regulating integrin-mediated cell adhesion and extracellular matrix 
assembly (Pan et al., 2008; Pan et al., 2006). An important question is what decides 
ALIX to function in ESCRT-mediated cellular processes or in ESCRT-independent 
cellular processes. 
1.6. The default intramolecular interaction of ALIX 
Native form of ALIX contains a default intramolecular interaction between Patch 
2 in Bro 1 domain and one of the TSG101 docking site (TSD: residues 717-720) in 
PRD (Fig. 5). This intramolecular interaction renders ALIX a closed conformation, 
which prohibits ALIX interaction with ESCRT-III component CHMP4 (Zhou et al., 2009; 
Zhou et al., 2008; Zhou et al., 2010). Thus, native form of ALIX cannot perform its 
ESCRT function. Also, ALIX in the closed conformation exists as the monomer in the 
cytosol. ALIX in the open conformation can dimerize through its V domain in an anti-
parallel manner and this dimerization was proposed to promote the assembly of 
CHMP4 filament and required for retroviral budding (Pires et al., 2009; Zhai et al., 
2008). Since ALIX is an essential mediator for linking the upstream initiator and the 
downstream executor of ESCRT-mediated processes, investigating the regulatory 
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mechanisms that relieve the intramolecular interaction of ALIX will lead to a better 
understanding for ESCRT-mediated processes. 
Based on the studies from previous graduate student in our group, three 
potential regulatory mechanisms that relieve the intramolecular interaction of ALIX were 
proposed. One is the partner protein interaction-induced conformational change. 
Another one is the competitive binding-induced disruption of intramolecular interaction. 
The third one is posttranslational modification-induced disruption of intramolecular 
interaction (Zhou et al., 2010).  
 
 
 
                      
 
 
 
 
 
 
 
 
 
18 
 
                                
Figure 5. Model depicting ALIX transforming from closed conformation to open 
conformation. Native form of ALIX contains a default intramolecular interaction 
between Patch 2 in Bro1 domain and TDS in N-terminal portion of PRD, rendering a 
closed conformation of ALIX and blocking its ESCRT-functions. The activation of ALIX 
initiates from the dissociation of Bro1 domain and PRD. Then, the V domain of ALIX is 
open followed by V-domain-mediated anti-parallel dimerization.  
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1.7. The objective of the dissertation 
The default intramolecular interaction of ALIX has to be relieved to activate 
ESCRT functions of ALIX. Thus, the objective of my dissertation research is to identify 
the regulatory mechanisms that activate the ESCRT functions of ALIX in the three 
classical ESCRT-mediated processes. To accomplish this objective, I performed three 
parts of studies. 
First, I comprehensively investigated the role of ALIX in binding, MVB sorting, 
silencing and degradation of activated EGFR in HEK293 and HeLa cells. My studies 
demonstrate that ALIX binds activated and ubiquitinated EGFR and plays an essential 
role in MVB sorting and timely silencing of activated EGFR. However, ALIX does not 
play an important role in trafficking of activated EGFR to lysosome for degradation. My 
studies thus identify ALIX as an important regulator for the signaling output of activated 
EGFR and possibly other receptor tyrosine kinases. 
Then, I explored the mechanism that relieves the default intramolecular 
interaction of ALIX in MVB sorting process. My studies demonstrate that calcium-
dependent ALG-2 interaction with ALIX induces a conformational change of ALIX that 
relieves its intramolecular interaction. ALG-2-supported activation of ALIX is required 
for ALIX to associate with membrane-bound CHMP4 and function in MVB sorting of 
activated EGFR. In contrast, ALG-2-supported activation of ALIX is not required for 
cytokinetic abscission or retroviral budding. My studies thus identify ALG-2 as a 
potential negative regulator of signaling transduction of activated EGFR and provide a 
new understanding for apoptotic induction effect of ALG-2. My studies also indicate that 
there should be other mechanisms that activate ESCRT function of ALIX in cytokinetic 
abscission and retroviral budding. 
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Further exploration demonstrate that ALIX is phosphorylated at the S718 and 
S721 residues, which locate at or near one of the intramolecular interaction sites, 
during mitotic entry and that this phosphorylation relieves the intramolecular interaction 
of ALIX in mitotic cells. This activating phosphorylation is required for inducing ALIX in 
open conformation that recruits CHMP4 to the midbody area and therefore essential for 
ALIX to support cytokinetic abscission. This activating phosphorylation also induces 
ALIX in open conformation that interacts with retroviral Gag proteins and therefore 
supports ALIX function in retroviral budding. In contrast, this phosphorylation is not 
important for MVB sorting function of ALIX. These findings provide a new 
understanding for the regulation of cytokinesis and retroviral budding and may provide 
new strategies for inhibiting cell division and retroviral budding.  
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Chapter 2: ALIX plays an essential role in MVB sorting of activated EGFR 
 
Contents of this chapter are based on Sun, S., Zhou, X., Zhang, W., Gallick, G.E., 
Kuang, J. Unravelling the pivotal role of Alix in MVB sorting and silencing of the 
activated EGFR. Biochem J. 2015;466(3):475-87. doi: 10.1042/BJ20141156. 
 
Copyright permission is not required. Portland Press policy states “As long as the 
original article, or portion of the article, is properly cited, and a link to the article is 
included, Authors retain the following non-exclusive rights: To include their article in 
whole or in part in their own dissertation or thesis in print or electronic format provided 
that the full-text article is not then shared in an open repository unless it is published via 
the Gold Open Access route.” 
 
Background 
 
EGFR is the model molecule for the study of ubiquitination-dependent 
endolysosomal trafficking of membrane receptors. EGF binding to plasma membrane 
EGFR induces the activation of EGFR, which is phosphorylated and ubiquitinated. The 
activated EGFR is internalized into cytoplasm through endocytosis and during this 
process, activated EGFR keeps on sending signals to its downstream pathways, such 
as ERK1/2. Then, the internalized EGFR is sorted into the ILVs of MVBs through MVB 
sorting. MVB sorting of activated EGFR is involved in timely terminating the signaling 
function of activated EGFR and delivering EGFR to lysosome for degradation 
(Gruenberg and Stenmark, 2004; Katzmann et al., 2002; Wegner et al., 2011). 
MVB sorting of activated EGFR is performed by ESCRTs and their associated 
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proteins. The ubiquitinated receptors are recognized and clustered by ESCRTs -0, -I, 
and -II. ESCRT-0 binds ubiquitinated receptors through both subunits, Hrs (HGF-
regulated tyrosine kinase substrate) and STAM1/2. ESCRT-I subunit TSG101 and 
ESCRT-II subunit hMvb12 are able to bind ubiquitinated receptors through their 
ubiquitin binding domain (UBD). The coordination of receptors recognition and 
membrane remodeling is achieved by the ability of ESCRT-II to both recognize the 
ubiquitinated receptors and initiate the assembly of highly oligomerized ESCRT-III 
complex. ESCRT-III subunit CHMP4 assembles into highly flexible filament that forms 
spirals at the surface of endosome membranes. CHMP4 spirals can deform under 
lateral compression and the relaxation of compressed CHMP4 spirals induces 
membrane deformation. Thus, ESCRT-III is the core machinery that performs the 
membrane scission at the budding site. ESCRT-III is timely disassembled by Vps4 
(Henne et al., 2011; Henne et al., 2013; Hurley and Hanson, 2010; Lata et al., 2009).  
Promoted by the previous reports that BRO1 plays a positive role in MVB sorting 
of ubiquitinated receptors in yeast (Pashkova et al., 2013) and that ALIX contains 
ubiquitin binding motifs, just as BRO1 does (Dowlatshahi et al., 2012; Pashkova et al., 
2013), I hypothesized that ALIX may be critically involved in MVB sorting of activated 
EGFR in mammalian cells.  
To test this hypothesis, I comprehensively study the role of ALIX in binding, MVB 
sorting, silencing and degradation of activated EGFR in mammalian cell lines. The 
results demonstrate that ALIX recognizes activated and ubiquitinated EGFR through its 
V domain and plays an essential role in MVB sorting and silencing of activated EGFR. 
However, ALIX does not have an essential role in lysosome-dependent degradation of 
activated EGFR. These findings identify ALIX as an important regulator of the signaling 
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output of activated EGFR and possibly other growth factor receptors. 
Results 
2.1.    ALIX interacts with activated and ubiquitinated EGFR through the V domain  
To determine whether ALIX recognizes ubiquitinated EGFR, I ectopically 
expressed GFP or GFP-ALIX in HEK293 cells, which were then mock-treated or 
stimulated with EGF, and examined the GFP-ALIX interaction with EGFR by using co-
immunoprecipitation (co-IP). Cell lysates were prepared from mock-treated and EGF-
stimulated cells with the membrane solubilizing lysis buffer containing 1% Triton X-100 
in the presence or absence of the deubiquitinase inhibitor N-ethylmaleimide (NEM). 
Cell lysates were immunoprecipitated with negative control mouse IgG or anti-GFP 
antibody, and the immunocomplexes were immunoblotted to visualize EGFR, 
ubiquitinated EGFR, GFP-ALIX and CHMP4B. As shown in Fig. 6A-B, in the presence 
of NEM, EGF stimulation increased the association of GFP-ALIX with EGFR by ~4 fold, 
and the ubiquitination of EGFR was confirmed by immunoblotting with anti-ubiquitin 
antibodies. However, in the absence of NEM, there is only basal level of association of 
GFP-ALIX with non-ubiquitinated EGFR, even with EGF stimulation. In contrast, the 
association of GFP-ALIX with CHMP4B had no change under all conditions. In contrast 
to GFP-ALIX, ectopically expressed GFP did not interact with EGFR, demonstrating 
that the association of GFP-ALIX with EGFR is a specific event (Fig. 6C).  These 
results identify two modes of interaction between ALIX and EGFR:  a high level of EGF-
induced and ubiquitination-dependent interaction and a low level of constitutive 
interaction. 
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Figure 6. ALIX interacts with activated and ubiquitinated EGFR. (A&B) HEK293 
cells were transfected with GFP-ALIX, serum starved for 12 h and stimulated with 100 
ng/ml EGF for indicated minutes. Crude cell lysates were extracted in the presence or 
absence of NEM.  (A) These cell lysates were directly immunoblotted to visualize 
EGFR, GFP-ALIX and CHMP4B. (B) These cell lysates were immunoprecipitated with 
anti-GFP antibody or mouse IgG followed by immunoblotting to visualize EGFR, 
ubiquitinated EGFR, GFP-ALIX and CHMP4b. Results represent two independent 
experiments. (C) HEK293 cells were transfected with GFP or GFP-ALIX, serum starved 
for 12 h and stimulated with 100 ng/ml EGF for indicated minutes. Crude cell lysates 
were prepared in the presence or absence of NEM and immunoprecipitated with anti-
GFP antibody. Input cell lysates and immunocomplexes were immunoblotted with 
indicated antibodies to visualize GFP, GFP-ALIX, EGFR and ubiquitinated EGFR. 
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To identify which domain of ALIX is responsible for ALIX interaction with EGFR, 
HEK293 cells were transfected with FLAG-ALIXBro1 or HA-ALIXV, and co-IP was 
performed to examine their interactions with EGFR. Cell lysates were prepared from 
mock-treated and EGF-stimulated cells with the membrane solubilizing lysis buffer in 
the presence of NEM. As shown in Fig. 7A, FLAG-ALIXBro1 only had low level of 
constitutive interaction with EGFR irrespective of EGF stimulation. In contrast, HA-
ALIXV had a high level of interaction with ubiquitinated EGFR in EGF-stimulated cells 
(Fig. 7B). These results indicate that ALIXBro1 is responsible for constitutive ALIX 
interaction with EGFR and that ALIXV is responsible for EGF-induced and 
ubiquitination-dependent ALIX interaction with EGFR. The membrane proteins from 
mock-treated or EGF-stimulated HEK293 cells were then extracted in the presence of 
NEM and GST pull-down was performed by using GST-ALIXBro1 or GST-ALIXV to 
examine their interactions with membrane-associated EGFR. As shown in Fig. 7C and 
Fig. 7D, although GST-ALIXBro1 could not pull down detectable EGFR, GST-ALIXV 
preferentially pulled down EGFR from EGF-stimulated cells. These results further 
support the conclusion that ALIXV mediates ALIX interaction with ubiquitinated EGFR in 
EGF-stimulated cells.  
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Figure 7. ALIX V domain interacts with activated and ubiquitinated EGFR. (A&B) 
HEK293 cells were transfected with FLAG-ALIXBro1 (A) or HA-ALIXV (B) and stimulated 
with 100 ng/ml EGF for indicated minutes. Cell lysates were prepared in the presence 
of NEM and immunoprecipitated with anti-FLAG antibody and mouse IgG (A) or anti-
HA antibody and mouse IgG (B). Cell lysates and immunocomplexes were 
immunoblotted to visualize EGFR and FLAG-ALIXBro1 in (A) or EGFR, ubiquitinated 
EGFR, and HA-ALIXV in (B). (C&D) Membrane proteins from HEK293 cells stimulated 
with 100 ng/ml EGF for indicated minutes were isolated and solubilized in the presence 
of NEM and incubated with immobilized GST and GST-ALIXBro1 in (C) or GST and 
GST-ALIXV in (D). Input and bound membrane proteins were immunoblotted to 
visualize EGFR, GST and GST-ALIXBro1 in (C) or EGFR, GST and GST-ALIXV in (D). 
Results represent two independent experiments.   
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2.2.   EGF-induced EGFR activation promotes ALIX interaction with membrane-
bound CHMP4  
ALIX involvement in all ESCRT-mediated processes requires ALIX interaction 
with membrane-bound CHMP4. Thus, to define the role of ALIX in MVB sorting of 
activated EGFR, I examined the interaction between ALIX and membrane-bound 
CHMP4. To this end, I fractionated post-nuclear supernatant (PNS) from mock-treated 
or EGF-stimulated HEK293 cells by using membrane flotation centrifugation. This 
established method utilized sucrose gradients (73%, 65% and 10%) to separate 
membrane vesicles (M) from soluble proteins (S) based on the density of membrane 
vesicles (Ono and Freed, 1999; Spearman et al., 1997). After ultracentrifugation, the 
membrane vesicles float at the interface between the layer of 65% sucrose and the 
layer of 10% sucrose, while the soluble proteins stay at the bottom.  As shown in Fig. 
8A, in mock-treated cells, ~13% of endogenous ALIX was membrane associated, and 
EGF stimulation increased the percentage of membrane associated ALIX to ~33%. 
Ectopically expressing wild type (WT) GFP-ALIX had the similar distribution as 
endogenous ALIX between M and S fraction in mock-treated and EGF-stimulated cells 
(Fig. 8B). However, only ~3% of CHMP4 interaction-defective mutant I212D GFP-ALIX 
associated with membrane in either mock-treated cells or EGF-stimulated cells (Fig. 
8B). These results demonstrate that EGF-induced EGFR activation promotes ALIX 
interaction with membrane bound CHMP4. 
ALIX can dimerize through the V domain in an antiparallel manner. This 
dimerization has been shown to promote assembly of CHMP4 filaments in vitro and be 
required for ALIX to support ESCRT-III-mediated retroviral budding (Pires et al., 2009). 
To determine whether membrane associated ALIX can dimerize through its V domain, I 
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first examined the dimerization of ALIX in whole cell lysates from HEK293 cells 
transfected with GFP-ALIX by using co-IP. The 1A3 anti-ALIX antibody, which 
recognizes both ALIX and HD-PTP (Zhou et al., 2009), was used for immunoblotting of 
input proteins and immunocomplexes. As shown in Fig. 8C, ectopically expressed 
GFP-ALIX interacted with endogenous ALIX, but not with detectable level of 
endogenous HD-PTP. I also performed co-IP of ectopically expressed GFP-ALIX and 
FLAG-ALIX to further examine the dimerization of ALIX (Fig. 8D-E). The results from 
this reciprocal co-IP further supported the conclusion. Together, these results 
demonstrate that membrane-associated ALIX can form a dimer through the interaction 
between the V domains.  
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Figure 8. EGF-induced EGFR activation promotes ALIX interaction with 
membrane-bound CHMP4. (A) HEK293 cells were serum starved for 12 h and either 
mock-treated or stimulated with 100 ng/ml EGF for 1 h. The PNS was fractionated by 
membrane flotation centrifugation and 10 fractions were taken by pipette for each 
sample. The same volume of aliquot from each fraction was taken and immunoblotted 
with indicated antibodies to visualize EEA1, ALIX and CHMP4b. (B) HEK293 cells were 
transfected with WT or I212D GFP-ALIX and serum starved for 12 h before being 
processed as described for (A). (C) HEK293 cells were transfected with GFP or GFP-
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ALIX. Lysates of the transfected cells were immunoprecipitated with IgG or anti-GFP 
antibody, and immunocomplexes were immunoblotted with indicated antibodies to 
visualize GFP and GFP-ALIX (top panel) and endogenous ALIX, GFP-ALIX and 
endogenous HD-PTP (lower panel). (D) HEK293 cells were transfected with FLAG-
ALIX and either GFP or GFP-ALIX. The crude cell lysates were immunoprecipitated 
with anti-GFP antibody or IgG. Input cell lysates and immunocomplexes were then 
immunoblotted with indicated antibodies to visualize GFP, GFP-ALIX and FLAG-ALIX. 
(D) HEK293 were transfected with GFP-ALIX and either FLAG or FLAG-ALIX. The 
crude cell lysates were immunoprecipitated with anti-FLAG antibody or IgG. Input cell 
lysates were immunocomplexes were then immunoblotted with indicated antibodies to 
visualize GFP-ALIX and FLAG-ALIX. 
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2.3.     ALIX plays a pivotal role in MVB sorting of activated EGFR  
The previous results showing that ALIX binds activated and ubiquitinated EGFR 
and that EGFR activation promotes ALIX association with membrane-bound CHMP4 
generated a hypothesis that ALIX is positively involved in MVB sorting of activated 
EGFR. To test this hypothesis, I first examined MVB sorting of activated EGFR by 
using proteinase K protection assay, which involves isolation of intracellular membrane 
vesicles after the plasma membrane is specifically dissolved by digitonin treatment. 
The membrane vesicles were digested by proteinase K in the presence or absence of 
0.1% Triton X-100. Since proteinase K cannot digest the EGFR that localizes within the 
lumen of the intact endosome, the percentage of proteinase K-insensitive EGFR in the 
absence of 0.1% Triton X-100 indicates the percentage of activated EGFR that is 
sorted into ILVs of MVB (Dores et al., 2012a; Malerod et al., 2007). As shown in Fig. 9A, 
after EGF stimulation for 30 min, the percentage of proteinase K-insensitive EGFR 
increased from ~5% to ~60%. EEA1, which is the peripheral endosome membrane 
protein, was used to demonstrate the efficient digestion by proteinase K.  
To determine whether ALIX interaction with CHMP4 is required to support MVB 
sorting of activated EGFR under EGF continuous stimulation condition, I transfected 
HEK293 cells with FLAG-ALIXBro1 to compete with endogenous ALIX in binding CHMP4 
and examined the effect on MVB sorting of activated EGFR. As shown in Fig. 9B, 
ectopically expressing WT FLAG-ALIXBro1, but not I212D FLAG-ALIXBro1, dramatically 
reduced the percentage of proteinase K-insensitive EGFR from ~60% to ~5%. The 
results demonstrate that ALIX interaction with CHMP4 plays an essential role in MVB 
sorting of activated EGFR. 
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To determine whether V domain-mediated ALIX dimerization is required to 
support MVB sorting of activated EGFR under EGF continuous stimulation condition, I 
transfected HEK293 cells with HA-ALIXV to compete with endogenous ALIX in 
dimerization and examined the effects on MVB sorting of activated EGFR. As shown in 
Fig. 9C, ectopically expressing WT HA-ALIXV, but not dimerization mutated (DM) HA-
ALIXV, dramatically reduced the percentage of proteinase K-insensitive EGFR from ~60% 
to ~5%. Co-IP assay demonstrated that ectopically expressing WT HA-ALIXV interacts 
with ALIX, but not HD-PTP, excluding the possibility that the inhibitory effects of WT 
HA-ALIXV is due to the interaction with HD-PTP (Fig. 9D). The results demonstrate that 
V domain-mediated ALIX dimerization is required for ALIX to support MVB sorting of 
activated EGFR. 
To further determine the role of ALIX in MVB sorting of activated EGFR under 
EGF continuous stimulation condition, I transfected HEK293 cells with ALIX targeting 
siRNA (si-ALIX) with or without co-expressing siRNA-insensitive GFP-ALIX (GFP-ALIX*) 
and examined the effects on MVB sorting of activated EGFR. As shown in Fig. 9E, 
knockdown of ALIX decreased the percentage of proteinase K-insensitive EGFR from 
~50% to ~15%. While ectopic expression of WT GFP-ALIX* rescued the inhibitory 
effects of ALIX knockdown, ectopic expression of I212D GFP-ALIX* or DM GFP-ALIX* 
did not have this rescuing effect. These results further demonstrate that CHMP4-bound 
ALIX dimer plays an essential role in MVB sorting of activated EGFR. 
Multiple previous studies used EGF pulse-chase condition to study the role of 
ALIX in degradation of activation of EGFR. Here, I examined the role of CHMP-4 bound 
ALIX dimer in MVB sorting of activated EGFR under EGF pulse-chase condition. 
Serum-starved cells were incubated with EGF at 4C for 30 min (EGF pulse) and then 
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cultured at 37C in the absence of EGF (chase) for indicated lengths of time. As shown 
in Fig. 9F, ectopic expression of WT HA-ALIXV or FLAG-ALIXBro1, or knockdown of 
ALIX decreased percentage of protected EGFR from ~40% to <10% under EGF pulse-
chase condition. 
Together, these results demonstrate that CHMP4-bound ALIX dimer plays an 
essential role in MVB sorting of activated EGFR under both EGF continuous stimulation 
condition and EGF pulse-chase condition.  
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Figure 9. ALIX plays a pivotal role in MVB sorting of activated EGFR. (A) HEK 293 
cells were mock-treated or EGF stimulated for 30 min. The proteinase K protection 
assay was performed to determine the percentage of proteinase K-insensitive EGFR. 
(B) HEK293 cells were transfected with FLAG, FLAG-ALIXBro1 or I212D FLAG-ALIXBro1. 
The proteinase K protection assay was performed to determine the percentage of 
proteinase K-insensitive EGFR. (C) HEK293 cells were transfected with HA, WT HA-
ALIXV, or DM HA-ALIXV. The proteinase K protection assay was performed to 
determine the percentage of proteinase K-insensitive EGFR. (D) HEK293 cells were 
transfected with HA-ALIXV, and the cell lysates were immunoprecipitated with anti-HA 
antibody or IgG. Input and immunocomplexes were immunoblotted with indicated 
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antibodies to visualize endogenous ALIX, endogenous HD-PTP and HA-ALIXV. (E) 
HEK293 cells were first transfected with si-NC or si-ALIX and cultured for 48 h. These 
cells were then transfected with constructs for indicated proteins and cultured for 
another 24 h. The proteinase K protection assay was performed to determine the 
percentage of proteinase K-insensitive EGFR. (F) HEK293 cells were transfected as 
indicated and stimulated with 100 ng/ml EGF under pulse-chase condition. The 
proteinase K protection assay was performed to determine the percentage of 
proteinase K-insensitive EGFR. 
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2.4.   ALIX plays an important role in terminating the downstream signaling of 
activated EGFR         
ERK1/2 is the major downstream signaling of activated EGFR, and EGF-induced 
ERK1/2 activation is a highly transient event (Xu et al., 2012), due to the rapid silencing 
of activated EGFR by MVB sorting and the dephosphorylation by phosphatase.  
To further support the conclusion that ALIX plays an essential role in MVB 
sorting of activated EGFR, I examined the roles of ALIX interaction with membrane-
bound CHMP4 in terminating the downstream signaling of activated EGFR. For this 
purpose, HEK293 cells were transfected with Y319F FLAG-ALIXBro1 and the effects on 
the kinetics of EGF-induced ERK1/2 activation were examined under EGF continuous 
stimulation condition. The construct contains Y319F mutation to eliminate its interaction 
with Src (Schmidt et al., 2005). As shown in Fig. 10A, under EGF continuous 
stimulation condition, ERK1/2 activation was highly transient in mock-transfected cells, 
reaching to the peak level at 10 min and then decreasing dramatically to the basal level 
at 30 min. The ERK1/2 activation continued decreasing afterward to nearly 
undetectable level from 1 h to 3 h. In contrast, ectopic expression of Y319F FLAG-
ALIXBro1 inhibited the decrease of ERK1/2 activation and prolonged the duration of 
ERK1/2 activation up to 3 h.   
To determine whether V domain-mediated ALIX dimerization plays an important 
role in terminating the downstream signaling of activated EGFR, HEK293 cells were 
transfected with HA-ALIXV and the effects on the kinetics of EGF-induced ERK1/2 
activation were examined under EGF continuous stimulation condition. Similar to the 
ectopic expression of Y319F FLAG-ALIXBro1, ectopic expression of HA-ALIXV also 
prolonged the duration of ERK1/2 activation up to 3 h (Fig. 10B).  
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To further determine the role of ALIX in terminating the downstream signaling of 
activated EGFR, HEK293 cells were transfected with control siRNA or si-ALIX and the 
effects on the kinetics of EGF-induced ERK1/2 activation were examined under EGF 
continuous stimulation condition. Similarly, knockdown of ALIX prolonged the duration 
of ERK1/2 activation up to 3 h (Fig. 10C).  
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Figure 10. ALIX plays an important role in terminating the downstream signaling 
of activated EGFR under EGF continuous stimulation condition. (A) HEK293 cells 
were transfected with FLAG or Y319F FLAG-ALIXBro1 and were stimulated with 100 
ng/ml EGF for indicated minutes (left panel) or hours (right panel). Cell lysates were 
immunoblotted with indicated antibodies to visualize phosphorylated ERK1/2 (p-
ERK1/2), ERK1/2, FLAG-ALIXBro1 and actin. (B) HEK293 cells were transfected with 
HA or HA-ALIXV and were stimulated with 100 ng/ml EGF for indicated minutes (left 
panel) or hours (right panel). Cell lysates were immunoblotted with indicated antibodies 
to visualize p-ERK1/2, ERK1/2, HA-ALIXV and actin. (C) HEK293 cells were transfected 
with indicated siRNAs and stimulated with 100 ng/ml EGF for indicated minutes (left 
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panel) or hours (right panel). Cell lysates were immunoblotted with indicated antibodies 
to visualize p-ERK1/2, ERK1/2, ALIX and actin. 
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Then, I further determined whether ALIX plays an important role in terminating 
the downstream signaling of activated EGFR under EGF pulse-chase condition. Similar 
to the results obtained under EGF continuous stimulation condition, EGF-induced 
ERK1/2 activation decreased to nearly undetectable level from 1 h to 3 h. Ectopic 
expression of FLAG-ALIXBro1 or HA-ALIXV, or transfection of si-ALIX inhibited the 
decrease and prolonged the duration of ERK1/2 activation up to 3 h (Fig. 11A-C).  
Together, these results demonstrate that CHMP4-bound ALIX dimer plays an 
important role in rapidly terminating the downstream signaling of activated EGFR under 
both EGF continuous stimulation and pulse-chase conditions and further support the 
essential role of CHMP4-bound ALIX dimer in MVB sorting of activated EGFR. 
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Figure 11. ALIX plays an important role in terminating the downstream signaling 
of activated EGFR under EGF pulse-chase condition. (A) HEK293 cells were 
transfected with FLAG or Y319F FLAG-ALIXBro1 and stimulated with 100 ng/ml EGF for 
30 min (pulse) followed by incubation for indicated hours (chase). Cell lysates were 
immunoblotted with indicated antibodies to visualize p-ERK1/2, ERK1/2, FLAG-ALIXBro1 
and actin. (B) HEK293 cells were transfected with HA or HA-ALIXV and stimulated with 
100 ng/ml EGF for 30 min (pulse) followed by incubation for indicated hours (chase). 
Cell lysates were immunoblotted with indicated antibodies to visualize p-ERK1/2, 
ERK1/2, HA-ALIXV and actin. (C) HEK293 cells were transfected with indicated siRNAs 
and stimulated with 100 ng/ml EGF for 30 min (pulse) followed by incubation for 
indicated hours (chase).  Cell lysates were immunoblotted with indicated antibodies to 
visualize p-ERK1/2, ERK1/2, ALIX and actin. 
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2.5.   Depleting the CHMP4-bound ALIX dimer retards EGF-induced degradation 
of activated EGFR 
To determine whether ALIX-supported MVB sorting is required for EGF-induced 
degradation of activated EGFR, I examined the effects of depleting CHMP4-bound 
ALIX dimer on the kinetics of EGF-induced EGFR degradation under both EGF 
continuous stimulation and EGF pulse-chase conditions. 
To determine whether ALIX interaction with membrane-bound CHMP4 plays a 
role in degradation of activated EGFR under EGF continuous stimulation condition, 
HEK293 cells were transfected with FLAG, Y319F FLAG-ALIXBro1 or Y319F-I212D 
FLAG-ALIXBro1 and stimulated with EGF for different time points. EGF stimulation 
induced progressive reduction in EGFR protein level in mock-transfected and Y319F-
I212D FLAG-ALIXBro1 transfected cells. In contrast, ectopic expression of Y319F FLAG-
ALIXBro1 inhibited EGFR degradation and increased the percentages of remaining 
EGFR at 1, 2, 3 and 4 h (Fig. 12A).  
To determine whether V domain-mediated ALIX dimerization plays a role in the 
degradation of activated EGFR under EGF continuous stimulation condition, HEK293 
cells were transfected with HA, WT HA-ALIXV or DM HA-ALIXV and stimulated with 
EGF for different time points. Similar to the results of ectopic expression of FLAG-
ALIXBro1, ectopic expression of WT HA-ALIXV, but not DM HA-ALIXV, increased the 
percentages of remaining EGFR at 30 min, 1, 2, 3 and 4 h (Fig. 12B). 
To further determine the role of CHMP-4 bound ALIX dimer in the degradation of 
activated EGFR under EGF continuous stimulation condition, HEK293 cells were 
transfected with si-ALIX with or without co-transfection of indicated forms of GFP-ALIX* 
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and the effects on degradation of activated EGFR were examined. As shown in Fig. 
12C-E, EGF continuous stimulation induced a progressive reduction in EGFR protein 
level in mock-transfected cells. In contrast, knockdown of ALIX increased the 
percentages of remaining EGFR at 1, 2, 3 and 4 h. Although ectopic expression of WT 
GFP-ALIX* could rescue the effects of ALIX knockdown, ectopic expression of I212D 
GFP-ALIX* or DM GFP-ALIX* did not have the rescuing effects.  
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Figure 12. Depletion of the CHMP4-bound ALIX dimer retards EGF-induced 
degradation of activated EGFR under EGF continuous stimulation condition. (A) 
HEK293 cells were transfected with FLAG and indicated forms of FLAG-ALIXBro1 and 
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stimulated with 100 ng/ml EGF for indicated hours. Cell lysates were immunoblotted 
with indicated antibodies to visualize EGFR, FLAG-ALIXBro1 and actin. (B) HEK293 
cells were transfected with HA and indicated forms of HA-ALIXV expressing cells and 
stimulated with 100 ng/ml EGF for indicated hours. Cell lysates were immunoblotted 
with indicated antibodies to visualize EGFR, HA-ALIXV and actin. (C-E) HEK293 cells 
transfected with indicated siRNA and indicated siRNA-insensitive constructs were 
stimulated with 100 ng/ml EGF for indicated hours. Cell lysates were immunoblotted 
with indicated antibodies to visualize EGFR, ALIX, GFP-ALIX and actin.  
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To determine the role of CHMP4-bound ALIX dimer in the degradation of 
activated EGFR under EGF pulse-chase condition, the effects of ectopic expression of 
Y319F FLAG-ALIXBo1 or HA-ALIXV or knockdown of ALIX on degradation of activated 
EGFR were examined. As shown in Fig. 13, EGF pulse-chase stimulation induced a 
progressive reduction in EGFR protein level in mock-transfected cells. Ectopic 
expression of Y319F FLAG-ALIXBo1 or HA-ALIXV increased the percentages of 
remaining EGFR at 1 and 2 h. Knockdown of ALIX only increased the percentage of 
remaining EGFR at 1 h.  
All these results demonstrate that ALIX-supported MVB sorting of activated 
EGFR is not essential for trafficking of activated EGFR to lysosomes for degradation. 
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Figure 13. Depletion of the CHMP4-bound ALIX dimer retards EGF-induced 
degradation of activated EGFR under EGF pulse-chase condition. (A) HEK293 
cells were mock-transfected or transfected with Y319F FLAG-ALIXBro1 or HA-ALIXV and 
stimulated with 100 ng/ml EGF for 30 min (pulse) followed by incubation for indicated 
hours (chase). Cell lysates were immunoblotted with indicated antibodies to visualize 
EGFR, FLAG-ALIXBro1 HA-ALIXV and actin. (B) HEK293 cells were transfected with 
indicated siRNAs and stimulated with 100 ng/ml EGF for 30 min (pulse) followed by 
incubation for indicated hours (chase).  Cell lysates were immunoblotted with indicated 
antibodies to visualize EGFR, ALIX and actin. 
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Discussion 
Although my current study clearly demonstrate that the CHMP4-bound ALIX 
dimer plays an essential role in MVB sorting and silencing of activated EGFR under 
both EGF continuous stimulation and pulse-chase conditions, multiple previous studies 
led to a widely held notion that ALIX is not critically involved in ESCRT-mediated MVB 
sorting of ubiquitinated receptors due to the obtained negative results that ALIX 
knockdown had no or only a minor inhibitory effect on trafficking of activated EGFR to 
lysosomes for degradation under the EGF pulse-chase stimulation condition (Bowers et 
al., 2006; Cabezas et al., 2005; Doyotte et al., 2008; Schmidt et al., 2004). In this study, 
I demonstrate the validity of the previous observations that ALIX is not essential for 
lysosome-dependent degradation of activated EGFR. However, the previous studies 
did not directly examine the effects of ALIX knockdown on MVB sorting of activated 
EGFR; instead, they used lysosome-dependent degradation of activated EGFR as the 
indicator of MVB sorting because of a widely held notion that MVB sorting is required 
for trafficking activated EGFR to lysosome for degradation. However, multiple studies 
showed that even the MVB sorting process is inhibited, cell surface receptors can still 
be delivered to lysosome for degradation, although at a slower rate (Futter et al., 2001; 
White et al., 2006). These studies, together with my current studies, support a logical 
explanation that trafficking of activated EGFR to lysosomes for degradation in 
mammalian cells can be achieved through both MVB sorting-dependent and -
independent mechanism and that ALIX is only involved in the MVB sorting-dependent 
mechanism.   
Although MVB sorting is not required for trafficking of activated EGFR to 
lysosome for degradation in mammalian cells, it can work with a tyrosine phosphatase 
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to terminate the downstream signaling of activated EGFR much earlier than EGFR 
degradation. My results show that under both EGF continuous and pulse-chase 
stimulation conditions, inhibition of the ALIX-supported MVB sorting of activated EGFR 
prolong the duration of EGF-induced activation of ERK1/2 from <20 min to >2 h. These 
results indicate that ALIX-supported MVB sorting is one of the major players in rapidly 
silencing the signaling function of activated EGFR and predict that cells may regulate 
the signaling output of activated EGFR or possibly other receptor tyrosine kinases 
through regulating whether activated receptor is degraded through MVB sorting 
pathway or the alternative pathway.  
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Chapter 3: The mechanism that activates ESCRT function of ALIX in MVB sorting 
of activated EGFR 
 
Contents of this chapter are based on Sun, S., Zhou, X., Corvera, J., Gallick, G.E., Lin, 
S., Kuang, J. ALG-2 activates the MVB sorting function of ALIX through relieving its 
intramolecular interaction. Cell Discovery 2015; 1,15018. doi:10.1038/celldisc.2015.18 
 
Copyright permission is not required. Nature Publishing Group policy states “You may 
reuse this material without obtaining permission from Nature Publishing Group, 
providing that the author and the original source of publication are fully acknowledged, 
as per the terms of the license.” 
 
Background 
 
The studies from the previous chapter demonstrate the essential role of ALIX in 
ESCRT-mediated MVB sorting of activated EGFR. ALIX involvement in ESCRT-
mediated processes requires ALIX interaction with CHMP4. However, the native form 
of ALIX contains a default intramolecular interaction, which renders a closed 
conformation of ALIX and prohibits ALIX interaction with CHMP4 (Zhou et al., 2009; 
Zhou et al., 2010). This predicts that ALIX involvement in ESCRT-mediated processes 
requires an activation step that relieves the intramolecular interaction of ALIX.  
ALG-2 was originally identified through a functional screen of genes critical for T-
cell receptor (TCR)-induced programmed cell death in T cell hybridoma (Vito et al., 
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1996). ALG-2 is a 22 kDa calcium-binding protein that interacts with ALIX in a calcium-
dependent manner (Missotten et al., 1999; Vito et al., 1999). ALG-2 possesses two 
high-affinity calcium-binding sites (Lo et al., 1999) and mutation of the Glu47 and Glu114 
residues to Ala (E47A/E114A) within both calcium-binding sites completely disrupts the 
calcium-binding capacity of ALG-2 (Lo et al., 1999). Calcium binding induces 
conformational change of ALG-2 and enables ALG-2 to bind four consecutive PxY 
motifs (PPYPTYPGYPGY at 802-813) near the C-terminus of ALIX (Missotten 
MTrioulier et al., 2004; Shibata et al., 2004). There is a spliced form of ALG-2, named 
as ALG-2.1, which lacks the amino acid residues Gly121 and Phe122. Although ALG-2.1 
is still able to bind to calcium, it cannot interact with ALIX (Marsh and McMahon, 1999). 
The ALG-2 binding region in ALIX (802-813) is outside the region that forms 
intramolecular interaction (1-746). Thus, the intramolecular interaction of ALIX should 
not block ALIX interaction with ALG-2. Indeed, ALG-2 has been shown to be able to 
bind native form of recombinant ALIX in a calcium-dependent manner (Missotten et al., 
1999; Vito et al., 1999). Moreover, inhibiting ALX interaction with ALG-2 by ectopic 
expression of a C-terminal fragment of ALIX or mutation of the ALG-2 binding site in 
ALIX attenuated the ability of ALIX in apoptotic induction (Mahul-Mellier et al., 2006; 
Mahul-Mellier et al., 2008), indicating that ALG-2 may be the regulator of the functions 
of ALIX. Due to its characteristics of calcium-binding, ALG-2 belongs to calmodulin 
superfamily, and the calmodulin has been demonstrated to regulate the conformational 
change of its partner proteins through relieving the intramolecular interaction of these 
partner proteins (Hoffman et al., 2011), indicating that ALG-2 may be able to regulate 
ALIX through similar mechanisms.  Endocytosis of activated receptor tyrosine kinases, 
which precedes MVB sorting, induces a rapid increase of calcium concentration in the 
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vicinity of endosome (Gerasimenko et al., 1998; Gerasimenko and Tepikin, 2005), 
indicating that internalization of activated EGFR may be linked to ALG-2 conformational 
change and its interaction with ALIX. Moreover, the studies from the previous graduate 
student in our group, Xi Zhou, showed that knockdown of ALG-2 retarded degradation 
of ectopically expressed EGFR in HEK293 cells. 
All these observations predict that calcium-dependent ALG-2 interaction with 
ALIX may be one of the mechanisms by which the intramolecular interaction of ALIX is 
relieved and the ESCRT functions of ALIX are activated. The preliminary data from the 
previous graduate student in our group also indicated that calcium-dependent ALG-2 
interaction with ALIX may induce the open conformation of ALIX. To further test this 
prediction, a series of conformation-sensitive and -insensitive anti-ALIX monoclonal 
antibodies, which were produced in our previous studies (Zhou et al., 2009; Zhou et al., 
2008), were used to examine the conformational change of ALIX. Conformation-
sensitive anti-ALIX antibodies 1A3 and 2H12 recognize Patch 2/Src binding site and 
F676 pocket/Viral Gag binding site, respectively. In contrast, conformation-insensitive 
anti-ALIX antibodies 1A12 and 3A9 recognize the epitope in the V domain that is not 
blocked by intramolecular interaction. Thus, the 1A3 and 2H12 antibodies only 
immunoprecipitate ALIX in its open conformation; the 1A12 and 3A9 antibodies 
immunoprecipitate ALIX in both open and closed conformations.  
My study demonstrates that calcium-dependent ALG-2 interaction with ALIX 
relieves the intramolecular interaction of ALIX and specifically activates the MVB 
sorting function of ALIX. 
 
Results 
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3.1.  Calcium-dependent ALG-2 interaction with ALIX transforms ALIX from 
closed conformation to open conformation 
I first verified the calcium-dependent ALG-2 interaction with ALIX in our 
experimental system by using GST pull-down. In the presence of 10 µM CaCl2 but 
absence of EGTA, GST-ALG-2 pulled down ALIX from HEK293 cytosolic proteins 
prepared without detergent. In the presence of EGTA but absence of CaCl2, GST-ALG-
2 did not pull down detectable level of ALIX. In the absence of CaCl2 and EGTA, GST-
ALG-2 still pulled down detectable level of ALIX, although the level is much less than 
that in the presence of CaCl2,  possibly due to the endogenous calcium in the cytosolic 
protein lysate (Fig. 14A). I also verified that WT GST-ALG-2, but not E47A/E114A (Mut) 
GST-ALG-2, pulled down ALIX from HEK293 cytosolic proteins in the presence of 10 
µM CaCl2 (Fig. 14B). 
To determine whether calcium-dependent ALG-2 interaction with ALIX relieves 
the intramolecular interaction of ALIX, I added GST or GST-ALG-2 to the cytosolic 
fraction of HEK293 cells and immunoprecipitated ALIX with the 2H12 or 1A12 
antibodies in the absence of detergent. Due to the background level of calcium in the 
cytosolic fraction, which may activate a small portion of GST-ALG-2, the 2H12 antibody 
immunoprecipitated a low level of ALIX from cytosolic fraction incubated with GST-
ALG-2. As a positive control, the 1A12 antibody immunoprecipitated similar level of 
ALIX from cytosolic fraction incubated with GST or GST-ALG-2 (Fig. 14C). 
Since the intramolecular interaction of ALIX prohibits ALIX interaction with its 
partner proteins, such as CHMP4 and TSG101, I further determined the effects of 
calcium-dependent ALG-2 interaction with ALIX on the conformational change of ALIX 
by examining the co-IP of ALIX and its partner proteins. For this purpose, I added 
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noting, CaCl2, or CaCl2 plus GST-ALG-2 to the cytosolic fraction of HEK293 cells 
ectopically expressing FLAG-CHMP4b or FLAG-TSG101 and immunoprecipitated 
FLAG-CHMP4b or FLAG-TSG101 with an anti-FLAG antibody in the absence of 
detergent. The results showed that cytosolic ALIX did not immunoprecipitate with 
FLAG-CHMP4b or FLAG-TSG101 in control cells. In the presence of CaCl2, detectable 
level of ALIX was immunoprecipitated with FLAG-CHMP4b or FLAG-TSG101. In the 
presence of CaCl2 and GST-ALG-2, much higher level of ALIX was immunoprecipitated 
with FLAG-CHMP4b or FLAG-TSG101 (Fig. 14D-E). These results demonstrate that 
calcium-dependent ALG-2 interaction with cytosolic ALIX relieves the intramolecular 
interaction of ALIX and transforms ALIX from closed conformation to open 
conformation.  
To determine whether ALG-2-induced open formation of ALIX is reversible, I first 
induced the open conformation ALIX by adding CaCl2 plus GST-ALG-2 to cytosolic 
fractions of HEK293 cells and then dissociated GST-ALG-2 by adding EGTA to 
cytosolic fractions of the cells. As shown in Fig. 14F-G, adding CaCl2 plus GST-ALG-2 
relieved the intramolecular interaction of cytosolic ALIX, as demonstrated by 
immunoprecipitation with the 1A3 antibody. Adding EGTA reversed the conformational 
change of ALIX. However, if the cytosolic fractions contained ectopic expressing FLAG-
TSG101, GST-p6 or GST-p9 before adding EGTA, then EGTA treatment only partially 
reversed the conformational change of ALIX. These results demonstrate that ALG-2-
induced conformational change of ALIX is a reversible event and that occupation by 
partner proteins partially maintains the open conformation of ALIX.  
Altogether, these results demonstrate that calcium-dependent ALG-2 interaction 
with ALIX relieves the intramolecular interaction of ALIX and induces an open 
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conformation of ALIX and that the open conformation of ALIX can be partially 
maintained by newly recruited partner proteins after ALG-2 dissociation. 
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Figure 14. Calcium-dependent ALG-2 interaction with ALIX transforms ALIX from 
closed conformation to open conformation. (A&B) GST, WT GST-ALG-2 or Mut 
GST-ALG-2 was immobilized onto GSH beads, which were then incubated with the 
cytosolic fraction of HEK293 cell lysates containing CaCl2 or EGTA. Input proteins and 
bound proteins were immunoblotted with indicated antibodies to visualize ALIX, GST 
and GST-ALG-2. (C) GST or GST-ALG-2 was added into cytosolic proteins of HEK293 
cells, which were then immunoprecipitated with indicated antibodies. Input and 
immunocomplexes were immunoblotted with indicated antibodies to visualize ALIX, 
GST and GST-ALG-2. (D&E) HEK293 cells were transfected with FLAG-CHMP4B (D) 
or FLAG-TSG101 (E) and cytosolic proteins of the transfected cells were incubated 
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with CaCl2 or CaCl2 plus GST-ALG-2. These cytosolic proteins were 
immunoprecipitated followed by immunoblotting with indicated antibodies. (F) GST-
ALG-2 plus CaCl2 and GST or GST-p6 were added into cytosolic proteins extracted 
from HEK293 cells and incubated for 30 min. Then, the samples were treated with or 
without EGTA for 30 min before being immunoprecipitated with the 1A3 antibody. Input 
and immunocomplexes were immunoblotted with indicated antibodies to visualize ALIX, 
GST-ALG-2 and GST-p6. (G) The assay was performed as described for (F), except 
that GST-p6 was changed to GST-p9.  
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3.2.   Calcium-dependent ALG-2 interaction with ALIX is essential for CHMP4-
dependent ALIX membrane association 
I first determined whether ALIX association with the membrane is dependent on 
interaction with CHMP4 by using membrane flotation centrifugation. HEK293 cells were 
transfected with si-NC or a combination of two pairs of si-CHMP4B, and the distribution 
of ALIX in M fraction was examined. As shown in Fig. 15A, transfection of si-CHMP4B 
knocked down CHMP4B by ~70% and decreased the percentage of membrane 
associated ALIX from ~13% to ~5%. EEA1 and actin were used as internal control for 
membrane proteins and soluble proteins, respectively in order to eliminate the 
possibility of contamination. The results demonstrate that ALIX association with the 
membrane is dependent on CHMP4. 
To determine the effects of calcium-dependent ALG-2 interaction with ALIX on 
ALIX membrane association, HEK293 cells were transfected with FLAG or FLAG-ALG-
2 and the PNSs were fractionated by using membrane flotation centrifugation. If the 
cells were briefly treated with calcium ionophore A23187 before collection, ectopic 
expression of FLAG-ALG-2 increased the percentage of membrane associated ALIX 
from ~11% to ~53%. However, ectopic expression of FLAG-ALG-2 alone did not 
significantly increase the percentage of membrane associated ALIX (Fig. 15B-C).  
These results demonstrate that calcium-dependent ALG-2 interaction with ALIX 
promotes ALIX association with membrane. 
To determine whether ALG-2-induced increase in ALIX membrane association is 
dependent on CHMP4, HEK293 cells were co-transfected with FLAG-ALG-2 and WT, 
I212D or ALG-2 binding site-deleted (∆PxY) GFP-ALIX and briefly treated with calcium 
ionophore A23187 before collection. The results of membrane flotation centrifugation 
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showed that ectopic expression of FLAG-ALG-2 in conjunction with a brief calcium 
ionophore A23187 treatment increased WT GFP-ALIX membrane association similarly 
as it did to the endogenous ALIX. However, I212D or ∆PxY mutation abolished GFP-
ALIX membrane association (Fig. 15D). These results demonstrate that ALG-2-induced 
ALIX association with membrane is dependent on ALIX interaction with CHMP4.  
To further determine the role of ALG-2 in ALIX association with the membrane, 
HEK293 cells were transfected with si-NC or si-ALG-2 and the effects on ALIX 
association with the membrane was determined by membrane flotation centrifugation. 
The results showed that knockdown of ALG-2 decreased the percentage of membrane 
associated ALIX from ~13% to ~2-3%, suggesting that ALG-2 plays a physiological role 
in ALIX association with membrane (Fig. 15E-F).  
Altogether, these results demonstrate that Ca2+-dependent ALG-2 interaction 
with ALIX plays a rate-limiting role in CHMP-4 dependent ALIX association with 
membrane. 
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Figure 15. Calcium-dependent ALG-2 interaction with ALIX is essential for 
CHMP4-dependent ALIX membrane association. (A) HEK293 cells were transfected 
with si-NC or si-CHMP4B. PNSs from the transfected cells were fractionated by 
membrane flotation centrifugation. M and S protein fractions were immunoblotted to 
visualize ALIX, CHMP4B, EEA1 and actin. (B) HEK293 cells were transfected with 
FLAG or FLAG-ALG-2. PNSs were prepared from these transfected cells treated with 
calcium ionophore A23187 and processed as described in (A). (C) HEK293 cells were 
transfected with FLAG or FLAG-ALG-2. PNSs were prepared from these transfected 
cells and processed as described in (A). (D) HEK293 cells were co-transfected with 
FLAG or FLAG-ALG-2 and indicated forms of GFP-ALIX. PNSs were prepared from 
these transfected cells treated with calcium ionophore A23187 and processed as 
described in (A). (E-F) HEK293 cells were transfected with si-NC or si-ALG-2.  PNSs 
were prepared from these transfected cells processed as described in (A). 
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3.3. EGF-induced EGFR activation increases ALIX association with the 
membrane through promoting ALG-2 interaction with ALIX  
To determine the effects of EGF-induced EGFR activation on ALIX and ALG-2 
association with the membrane, HEK293 cells were stimulated with or without 100 
ng/ml EGF for 1 h and PNSs were prepared for membrane flotation centrifugation. The 
results showed that EGF stimulation not only increased the percentage of membrane-
associated ALIX from ~12% to ~35%, but also increased the percentage of membrane-
associated ALG-2 from ~11% to ~44%.  In contrast, the even distribution of CHMP4B 
between M fraction and S fraction was not changed (Fig. 16A).  
To determine whether EGF stimulation promotes ALG-2 interaction with ALIX, 
HEK293 cells were stimulated with or without EGF and the cell lysates were prepared 
with 0.1% Triton X-100 to dissolve the membrane and 10 µM CaCl2. The results of co-
IP showed that EGF stimulation increased ALG-2 interaction with ALIX by ~3.5 fold 
(Fig.16B).  
Since ALG-2 interaction with ALIX is calcium-dependent and endocytosis of cell 
surface receptors induces a spike of calcium near endosomes, I then determined 
whether calcium is required for EGF-induced increase in ALIX association with the 
membrane.  For this purpose, HEK293 cells were mock-treated or treated with cell 
permeable calcium chelator BAPTA-AM before EGF stimulation and the effects of 
BAPTA-AM treatment on ALIX association with the membrane was examined. As 
shown in Fig. 16C, BAPTA-AM treatment inhibited EGF-induced increase in ALIX 
association with the membrane. All these results suggest that calcium-dependent ALG-
2 interaction with ALIX is required for EGF-induced increase of ALIX association with 
the membrane. 
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To further test this assumption, I knocked down endogenous ALG-2 or 
overexpressed FLAG-ALG-2 in HEK293 cells and examined the effects on EGF-
induced ALIX association with the membrane. As shown in Fig. 16D, knockdown of 
ALG-2 decreased the percentages of membrane-associated ALIX to barely detectable 
level in both mock-treated and EGF-stimulated cells. In contrast, overexpression of WT 
FLAG-ALG-2, but not Mut FLAG-ALG-2, in EGF-stimulated cells increased the 
percentage of membrane-associated ALIX from ~35% to ~53% (Fig. 16E-F). HEK293 
cells were then transfected with WT GFP-ALIX, PxY GFP-ALIX or I212D GFP-ALIX 
and then stimulated with or without EGF. The membrane association of GFP-ALIX was 
determined by using membrane flotation centrifugation. As shown in Fig. 16G, EGF 
stimulation increased the membrane association of WT GFP-ALIX. In contrast, PxY 
GFP-ALIX or I212D GFP-ALIX was barely detectable. These results support our 
assumption.  
Altogether, these results demonstrate that EGF stimulation increases ALIX 
association with the membrane through promoting Ca2+-dependent ALG-2 interaction 
with ALIX.  
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Figure 16. EGF-induced EGFR activation increases ALIX association with the 
membrane through promoting ALG-2 interaction with ALIX. (A) Serum starved 
HEK293 cells were stimulated with or without EGF for 1 h. PNSs were prepared for 
membrane flotation centrifugation. (B) Serum starved HEK293 cells were stimulated 
with or without EGF for 1 h. Cell lysates were prepared in the presence of 0.1% Triton 
X-100 and 10 µM CaCl2 and immunoprecipitated with the 3A9 antibody. Input proteins 
and immunocomplexes were immunoblotted to visualize ALIX and ALG-2. (C) Serum 
starved HEK293 cells were treated with BAPTA-AM starting 1 h before EGF stimulation. 
PNSs were prepared for membrane flotation centrifugation. (D) HEK293 cells were 
transfected with si-ALG-2(1) and serum starved for 12 h before mock-treated or 
stimulated with EGF for 1 h. PNSs were prepared for membrane flotation centrifugation.  
(E&F) HEK293 cells were transfected with FLAG or WT FLAG-ALG-2 (E) or Mut FLAG-
ALG-2 (F) and serum starved for 12 h before stimulated with EGF for 1 h. PNSs were 
prepared for membrane flotation centrifugation. (G) HEK293 cells were transfected with 
indicated forms of GFP-ALIX and serum starved for 12 h. These cells were stimulated 
with or without EGF for 1 h.  PNSs were prepared for membrane flotation centrifugation. 
 
 
 
 
 
 
 
 
66 
 
3.4.     Membrane-associated ALIX is in an open conformation 
To determine whether membrane-associated ALIX is in an open conformation, 
M fraction and S fraction were fractionated by membrane floatation centrifugation and 
the pooled M fraction proteins and pooled S fraction proteins were extracted with 0.1% 
Triton X-100, which dissolves the membrane vesicles and preserves the intramolecular 
interaction of ALIX, and then immunoprecipitated with anti-ALIX antibodies. 5×M 
fraction proteins were used to make the total protein level is comparable to that of 1×S 
fraction proteins.  Although conformation-sensitive 1A3 antibody immunoprecipitated 
ALIX from 5×M fraction, it did not immunoprecipitate ALIX from 1×S fraction. In contrast, 
conformation-insensitive 3A9 antibody immunoprecipitated comparable levels of ALIX 
from 5×M fraction and 1×S fraction (Fig. 17A).  
To determine whether ALG-2-induced membrane-associated ALIX is in an open 
conformation, PNSs of HEK293 cells ectopically expressing FLAG-ALG-2 and being 
treated with calcium ionophore A23187 were fractionated by membrane flotation 
centrifugation. Pooled M fraction and pooled S fraction proteins were extracted with 0.1% 
Triton X-100 for co-IP with the 3A9 antibody. Although FLAG-ALG-2, TSG101 and 
CHMP4B were co-immunoprecipitated with ALIX in M fraction, no detectable levels of 
any of these three proteins were co-immunoprecipitated with ALIX in S fraction, 
indicating that ALIX in M fraction of FLAG-ALG-2 expressing cells is in an open 
conformation (Fig. 17B).  
To determine whether EGF-induced membrane-associated ALIX is in an open 
conformation, PNSs of HEK293 cells stimulated with EGF were fractionated by 
membrane flotation centrifugation. 5×pooled M fraction and 1×pooled S fraction 
proteins were extracted with 0.1% Triton X-100 for co-IP with the 3A9 antibody. The 
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results showed that ALIX in M fraction, but not S fraction, was co-immunoprecipitated 
with endogenous ALG-2 and CHMP4B (Fig. 17C).  
Altogether, these results demonstrate that EGF-induced and ALG-2-dependent 
membrane-associated ALIX is in an open conformation and interacts with partner 
proteins.  
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Figure 17. Membrane-associated ALIX is in an open conformation. (A) PNSs 
extracted from HEK293 cells were fractionated by membrane flotation centrifugation. 
5×volumes of M fractions were pooled and 1×volume of S fraction was pooled. These 
pooled M and S fractions were immunoprecipitated with indicated antibodies. Input and 
immunocomplexes were immunoblotted to visualize ALIX and IgG. (B) HEK293 cells 
were transfected with FLAG-ALG-2. The transfected cells were treated with calcium 
ionophore A23187 for 15 min before collection. PNSs were fractionated by membrane 
flotation centrifugation. Pooled M fraction and S fractions were immunoprecipitated with 
the 3A9 antibody. Input and immunocomplexes were immunoblotted to visualize ALIX, 
FLAG-ALG-2, TSG101, and CHMP4B. (C) HEK293 cells were serum starved for 12 h 
and then stimulated with or without EGF for 1 h. 5×volumes of M fractions were pooled 
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and 1×volume of S fraction was pooled. These pooled M and S fractions were 
immunoprecipitated with the 3A9 antibody. Input and immunocomplexes were 
immunoblotted to visualize ALIX, ALG-2, and CHMP4B. 
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3.5.    ALG-2-induced activation of ALIX plays an essential role in MVB sorting of 
activated EGFR at early endosomes 
The data demonstrating that calcium-dependent ALG-2 interaction with ALIX is 
essential for EGF-induced ALIX association with membrane suggests that ALG-2 may 
play an essential role in MVB sorting of activated EGFR. To test this hypothesis, I first 
examined whether knockdown of ALG-2 affects MVB sorting of activated EGFR by 
using proteinase K protection assay.  HEK293 cells were first transfected with si-NC or 
si-ALG-2 and then transfected with WT or Mut FLAG-ALG-2* and the effects on MVB 
sorting of activated EGFR were examined. The results showed that knockdown of ALG-
2 decreased the percentage of the proteinase K-insensitive EGFR from ~60% to ~17%.  
Ectopically expressing WT FLAG-ALG-2* rescued the percentage of the proteinase K-
insensitive EGFR to near control level. In contrast, ectopically expressing Mut FLAG-
ALG-2* only slightly rescued the defect in MVB sorting of activated EGFR (Fig. 18A).  
These results demonstrate that ALG-2 interaction with ALIX plays an essential role in 
MVB sorting of activated EGFR.  
To further test this hypothesis, HEK293 cells were first transfected with si-ALIX 
and then transfected with WT or PxY GFP-ALIX* and the effects on MVB sorting of 
activated EGFR were examined. Knockdown of ALIX decreased the percentage of the 
proteinase K-insensitive EGFR from ~60% to ~14%. Ectopically expressing WT GFP-
ALIX*, but not PxY GFP-ALIX*, rescued the defect in MVB sorting of activated EGFR 
(Fig. 18B). These results support our conclusion. 
I already demonstrated that ALIX-supported MVB sorting of activated EGFR is 
essential for rapidly terminating the downstream signaling of activated EGFR. Thus, I 
further examined the effects of ALG-2 on the kinetics of EGF-induced ERK1/2 
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activation under EGF continuous stimulation condition. As shown in Fig. 18C, EGF 
stimulation for 10 min induced the peak level of ERK1/2 activation and the activation of 
ERK1/2 dramatically decreased to basal level after 30 min of EGF stimulation. The 
level of ERK1/2 activation continued decreasing to nearly undetectable level from 1 h to 
3 h of EGF stimulation. Knockdown of ALG-2 prevented the decrease of ERK1/2 
activation in 1 h of EGF stimulation and promoted the sustained ERK1/2 activation from 
1 h to 3 h of EGF stimulation. These results demonstrate that ALG-2 plays an important 
role in regulating the downstream signaling of activated EGFR and also further support 
our conclusion that ALG-2 is required for ALIX-supported MVB sorting of activated 
EGFR.  
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Figure 18. ALG-2-induced activation of ALIX plays an essential role in MVB 
sorting of activated EGFR. (A) HEK293 cells were first transfected with si-NC or si-
ALG-2 and then mock-transfected or transfected with indicated forms of FLAG-ALG-2*. 
These cells were serum starved for 12 h and stimulated with EGF for 30 min before 
being measured by the proteinase K protection assay. (B) HEK293 cells were first 
transfected with si-NC or si-ALIX and then mock-transfected or transfected with 
indicated forms of GFP-ALIX*. These cells were serum starved for 12 h and stimulated 
with EGF for 30 min before being measured by the proteinase K protection assay. 
(C&D) HEK293 cells were transfected with si-NC or si-ALG-2 and serum starved for 12 
h before being stimulated with EGF for indicated minutes (C) or hours (D). Cell lysates 
were immunoblotted to visualize p-ERK1/2, ERK1/2 and actin. 
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Since endocytosis of activated EGFR is prerequisite for MVB sorting of activated 
EGFR, thus it is possible that the inhibitory effects of ALG-2 or ALIX knockdown on 
MVB sorting of activated EGFR is from the inhibitory effects on endocytosis. To test 
this possibility, I knocked down ALIX or ALG-2 in HEK293 cells and stimulated the 
serum-starved cells with EGF for indicated time points. Then, the levels of cell surface 
EGFR were examined by biotinylation of cell surface proteins followed by pull-down of 
these biotynlated proteins by streptavidin beads. Immunoblotting with anti-EGFR 
antibody showed that knockdown of ALIX only slightly decreased the percentage of cell 
surface EGFR at the time point of 10 min (Fig. 19A). Knockdown of ALG-2 did not 
affect the levels of cell surface EGFR before and after EGF stimulation (Fig. 19B). 
These results eliminate the possibility that endocytosis of activated EGFR plays any 
roles in ALG-2-ALIX-dependent MVB sorting of activated EGFR. 
To determine whether ALG-2/ALIX regulates MVB sorting of activated EGFR at 
early endosome or late endosome, I transfected HeLa cells with GFP-Rab5 (Q79L), 
which generates enlarged early endosome that can be observed by fluorescent 
microscope (Brankatschk et al., 2012; Raiborg et al., 2002), stimulated the serum-
starved cells with EGF for 30 min and examined the localization of EGFR by using 
immunostaining with an anti-EGFR antibody. In control knockdown cells, ~60% of 
EGFR localized within the GFP-labelled early endosomes. Knockdown of ALIX or ALG-
2 decreased the percentage of intraluminal EGFR to ~20% (Fig. 19C). These results 
support the role of ALG-2/ALIX in promoting MVB sorting of activated EGFR at early 
endosomes.  
To further test this conclusion, I treated HEK293 cells with microtubule poison 
nocodazole to block early to late endosome trafficking (Abrami et al., 2004) and 
74 
 
examined whether the inhibitory effects of ALG-2 knockdown on MVB sorting of 
activated EGFR was affected. The results of proteinase K protection assay showed that 
treatment with nocodazole did not affect the inhibitory effects of ALG-2 knockdown on 
MVB sorting of activated EGFR (Fig. 19D), further supporting our conclusion. 
Taken together, these results demonstrate that ALG-2 induced activation of 
ALIX promotes MVB sorting of activated EGFR at early endosome.  
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Figure 19. ALG-2/ALIX plays an essential role in MVB sorting of activated EGFR 
at early endosome. (A&B) HEK293 cells were transfected with si-NC or si-ALIX (A) or 
si-ALG-2 (B) and serum starved for 12 h before being stimulated with EGF for indicated 
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minutes. These cells were biotinylated and cell lysates extracted from these cells were 
incubated with streptavidin beads for pull-down of biotinylated cell surface proteins. 
Input and bound proteins were immunoblotted to visualize EGFR, ALIX and actin. (C) 
HeLa cells were first transfected with si-NC, si-ALIX or si-ALG-2 and then transfected 
with GFP-Rab5 (Q79L) before serum starvation for 12 h. These cells were stimulated 
with EGF for 30 min, fixed and stained with an anti-EGFR antibody (red). Total and 
intra-luminal EGFR were scored for 10 GFP-labeled endosomes for each condition, 
and the percentages of intra-luminal EGFR were determined. (D) HEK293 cells were 
transfected with si-NC or si-ALG-2 and serum starved for 12 h. These cells were 
treated with 10 µM nocodazole for 2 h before and during EGF stimulation before being 
measured by proteinase K protection assay.   
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3.6.   ALG-2-induced activation of ALIX plays an important role in EGF-induced 
EGFR degradation 
The results in the previous chapter showed that knockdown of ALIX inhibited 
MVB sorting of activated EGFR and retarded the degradation of activated EGFR under 
EGF continuous stimulation condition. Since ALG-2 is required for ALIX to support 
MVB sorting of activated EGFR, I hypothesized that ALG-2-induced activation of ALIX 
plays an important role in EGF-induced EGFR degradation under EGF continuous 
stimulation condition. To test this hypothesis, I first knocked down ALG-2 and examined 
the effects on the kinetics of EGF-induced EGFR degradation under EGF continuous 
stimulation condition. As shown in Fig. 20A-B, knockdown of ALG-2 increased the 
percentage of remaining EGFR at 1, 2, 3 and 4 h, resulting in retardation of the 50% 
EGFR degradation from 1 h to 2-2.5 h. Ectopically expressing WT FLAG-ALG-2*, but 
not Mut FLAG-ALG-2*, rescued the defect in EGFR degradation induced by knockdown 
of ALG-2. Then, WT or Mut FLAG-ALG-2 was overexpressed in HEK293 cells and the 
effect on EGF-induced EGFR degradation was examined. As shown in Fig. 20C, 
overexpression of WT FLAG-ALG-2, but not Mut FLAG-ALG-2 decreased the 
percentage of remaining EGFR at 1, 2 and 3 h, accelerating the 50% EGFR 
degradation from 1 h to 0.5 h. To further test the hypothesis, I examined the rescuing 
effects of WT or ∆PxY GFP-ALIX* on EGF-induced EGFR degradation in ALIX 
knockdown cells. As shown in Fig. 12C and 20D, WT, but not ∆PxY GFP-ALIX*, 
rescued the defect in EGFR degradation in ALIX knockdown cells. 
Taken together, these results demonstrate that ALG-2 induced activation of 
ALIX plays an important role in EGF-induced EGFR degradation under EGF continuous 
stimulation condition. 
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Figure 20. ALG-2-induced activation of ALIX plays an important role in EGF-
induced EGFR degradation.  (A&B) HEK293 cells were first transfected with si-NC or 
si-ALG-2(1) and then transfected with WT FLAG-ALG-2* (A) or Mut FLAG-ALG-2* (B) 
before being serum starved for 12 h. These cells were then stimulated with EGF for 
indicated hours, and cell lysates were immunoblotted to visualize EGFR, ALG-2, FLAG-
ALG-2 and actin. (C) HEK293 cells were transfected with WT FLAG-ALG-2 or Mut 
FLAG-ALG-2 before being serum starved for 12 h. These cells were then stimulated 
with EGF for indicated hours, and cell lysates were immunoblotted to visualize EGFR, 
FLAG-ALG-2 and actin. (D) HEK293 cells were transfected with si-NC or si-ALIX(1) 
and then transfected with ∆PxY GFP-ALIX* before being serum starved for 12 h. These 
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cells were then stimulated with EGF for indicated hours, and cell lysates were 
immunoblotted to visualize EGFR, ALIX, GFP-ALIX and actin. 
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3.7.  ALG-2 is not required for supporting ALIX to function in cytokinetic 
abscission or retroviral budding  
Besides MVB sorting function, ALIX has been demonstrated to be critically 
involved in cytokinetic abscission and retroviral budding. Since all these ESCRT-
mediated processes require relieving the intramolecular interaction of ALIX, I examined 
whether ALG-2 is also required for supporting ALIX to function in cytokinetic abscission 
and retroviral budding. First, I examined whether ALG-2 is required to support 
cytokinetic abscission. The failure in cytokinetic abscission induces multinucleated cells 
and midbody-stage cells. As a positive control, knockdown of ALIX in HeLa cells 
increased the percentages of multinucleated and midbody-stage cells from ~5% to ~35% 
(Fig. 21A), consistent with the previous studies (Carlton and Martin-Serrano, 2007; 
Morita et al., 2007). In contrast, knockdown of ALG-2 did not significantly increase the 
percentages of multinucleated and midbody-stage cells (Fig. 21A), suggesting that 
ALG-2 is not important for cytokinetic abscission.  
Then, I examined whether ALG-2 is required to support retroviral budding. For 
this purpose, I first knocked down ALG-2 in HEK293 cells by using siRNA and then 
transfected the cells with pEV53B-EIAVGAG.  Virus-like particles (VLPs) were collected 
from culture medium by ultracentrifugation. The levels of VLPs were examined by 
immunoblotting of VLP lysates using anti-capsid (CA) antibodies. As a positive control, 
knockdown of ALIX significantly inhibited EIAV budding from infected HEK293 cells 
(Fig. 21B), consistent with the previous reports (Strack et al., 2003; von Schwedler et 
al., 2003).  In contrast, knockdown of ALG-2 did not inhibit EIAV budding (Fig. 21B), 
suggesting that ALG-2 is not important for EIAV budding. 
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Taken together, these results suggest that ALG-2 specifically generates 
functional ALIX in MVB sorting of activated EGFR and that there should be other 
mechanisms by which ALIX is activated to function in cytokinetic abscission and 
retroviral budding.  
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Figure 21. ALG-2 is not required for supporting ALIX to function in cytokinetic 
abscission or retroviral budding. (A&B) HeLa cells were transfected with si-NC, si-
ALIX or si-ALG-2, fixed and stained with anti-tubulin antibodies (red) and 
counterstained with DAPI (blue). (A) Hollow arrows indicate multinucleated or midbody- 
stage cells. Scale bar: 50 µm. (B) Average percentages of multinucleated and 
midbody-stage cells and SDs for each condition were determined from three 
independent experiments and plotted (lower panel). (C&D) HEK293 cells were first 
transfected with si-NC, si-ALIX(1) or si-ALIX(2) (C) or with si-NC, si-ALG-2(1) or si-
ALG-2(2) (D) and then transfected with EIAV pEV53B. Released VLPs were collected 
by using ultracentrifugation. Cell lysates and VLPs were immunoblotted with anti-CA 
antibodies.  
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Discussion 
Results from the previous chapter demonstrate the essential role of CHMP4-
bound ALIX dimer in MVB sorting and silencing of activated EGFR. However, the 
default intramolecular interaction of ALIX inhibits MVB sorting function of ALIX through 
prohibiting ALIX interaction with CHMP4. Here, my studies demonstrate that calcium-
dependent ALG-2 interaction with ALIX completely relieves the intramolecular 
interaction of ALIX and promotes ALIX association with membrane-bound CHMP4. 
Although this mechanism is essential for activating ESCRT function of ALIX in MVB 
sorting of activated EGFR, it is not involved in activating ESCRT function of ALIX in 
cytokinetic abscission and retroviral budding.  
In default condition, only ~10%-15% of ALIX is membrane associated and this 
membrane association is dependent on ALG-2, indicating that calcium is one of the 
rate-limiting factors in this regulatory mechanism. However, treating cells with calcium 
ionophore A23187 alone only slightly increased the level of ALIX in open conformation. 
Combination of overexpressing ALG-2 and adding calcium ionophore A23187 
significantly increased the level of ALIX in open conformation, indicating that ALG-2 
availability is also the rate-limiting factor in this regulatory mechanism. 
Activation of EGFR induces a calcium spike near endosomes (Gerasimenko et 
al., 1998; Gerasimenko and Tepikin, 2005). Consistent with this, our results showed 
that EGF stimulation promoted ALG-2 interaction with ALIX. However, there is possible 
that EGFR activation also increases the availability of ALG-2. Although the underlining 
mechanism is still unknown, I predict that EGFR activation may induce the 
phosphorylation of ALG-2, which increases the availability of ALG-2. This prediction 
needs to be examined in the future studies. 
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ALG-2 was originally identified as apoptotic induction protein (Vito et al., 1996). 
The studies exploring the mechanisms of the pro-apoptotic function of ALG-2 identified 
ALIX as the ALG-2 interacting proteins and this interaction is essential for apoptotic 
induction. The studies in this chapter lead us to hypothesize that ALG-2 may induce 
apoptosis through terminating the downstream signaling of activated receptor tyrosine 
kinases. 
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Chapter 4: The mechanism that activates ALIX function in cytokinetic abscission 
and retroviral budding 
The contents of this chapter are based on Sun, S., Sun, L., Zhou, X., Wu, C., Wang, R., 
Lin, S.H., Kuang, J. Phosphorylation-Dependent Activation of the ESCRT Function of 
ALIX in Cytokinetic Abscission and Retroviral Budding. Dev Cell. 2016;36(3):331-43. 
doi: 10.1016/j.devcel.2016.01.001. 
 
Copyright permission is required and obtained from Cell Press (License No.: 
3830440570477). 
 
Background 
 
The results from chapter 3 showing that ALG-2 is not important for ALIX-
mediated cytokinetic abscission or retroviral budding suggest that there should be other 
mechanisms that activate ESCRT functions of ALIX in these two processes.  
Cytokinesis initiates during early anaphase with a primary ingression of the 
cleavage furrow mediated by contraction of the actomyosin ring. As furrowing 
progresses, the spindle midzone, which is the structure formed during anaphase 
between the separating chromosomes by overlapping spindle microtubules, transforms 
into the intercellular bridge. Two daughter cells are connected by the intercellular 
bridge, at the middle of which is a dense structure termed the midbody. The midbody 
contains antiparallel arrays of microtubules that cross the Flemming body, which is the 
electron-dense structure that forms at the center of the midbody when the spindle 
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midzone’s microtubules are compacted after furrow ingression. The midbody provides 
the anchorage to the ingressed cleavage furrow and the platform for the recruitment 
and assembly of ESCRTs. Before abscission occurs, a secondary ingression forms and 
decreases the thickness of the intercellular bridge from 1.5-2 µm to 100-200 nm 
(Agromayor and Martin-Serrano, 2013; Mierzwa and Gerlich, 2014). During late 
telophase, FIP3 endosomes deliver p50RhoGAP and SCAMP2/3 to the intercellular 
bridge, where SCAMP2/3 and p50RhoGAP are involved in depolymerization of the 
cortical actin. The depolymerization of the cortical actin is required for successful 
completion of abscission. Knockdown of SCAMP2/3 or p50RhoGAP was shown to 
significantly decrease the percentage of cells with secondary ingression. FIP3, 
SCAM2/3 or p50RhoGAP was also shown to be required for ESCRT machinery to be 
recruited to the abscission site to perform the final cut (Schiel et al., 2012). 
Before cytokinetic abscission, Cep55 is recruited to the midbody through the 
direct interaction between Cep55 and midbody component MKLP1 (mitotic kinesin-like 
protein 1) (Bastos and Barr, 2010). Cep55 recruits ESCRT-associated protein ALIX to 
the midbody through the direct interaction. ALIX in turn recruits ESCRT-III component 
CHMP4 to the midbody area and promotes the assembly of 17-nm ESCRT-III filament. 
Membrane abscission occurs ∼1 μm away from the midbody where the microtubules 
are removed by microtubule-severing protein, spastin, enabling full constriction at the 
abscission site. ESCRT-III filaments assemble at both the midbody and membrane 
abscission site but appear to be discontinuous (Carlton et al., 2008; Guizetti et al., 2011; 
Morita et al., 2007).  
The budding of enveloped viruses away from the infected cells is the process in 
which the membrane is distorted away from the cytoplasm and ultimately wrapped 
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around the assembling viral particles followed by severing membrane connected the 
viral particles and cells to release the viral particles (Martin-Serrano and Neil, 2011; 
Votteler and Sundquist, 2013).  Retroviral assembly and budding is driven primarily by 
Gag, a polyprotein that contains all the necessary domains. Retroviruses hijack 
ESCRTs in host cells through direct interaction between YPXL motif in L domain of 
Gag protein and the F676 pocket in ALIX (Martin-Serrano and Neil, 2011; Strack et al., 
2003; von Schwedler et al., 2003; Votteler and Sundquist, 2013). 
Previous studies of the Xenopus ortholog of ALIX, Xp95, during meiotic 
maturation of Xenopus oocytes showed that Xp95 is phosphorylated both at the 
conserved tyrosine residue (Y318) within the Patch 2 of the Bro1 domain (Dejournett et 
al., 2007), and at multiple sites within N-terminal portion of PRD (nPRD) in M phase-
arrested mature oocytes (Dejournett et al., 2007). Alignment of the sequence of Xp95 
and ALIX showed that most of the phosphorylation sites within the Bro1 domain and 
nPRD are conserved. Since protein phosphorylation may disrupt the intramolecular 
interaction of a protein, we hypothesized that phosphorylation of one or both of the 
intramolecular interaction sites in ALIX relieves the intramolecular interaction of ALIX 
and transforms ALIX from closed to open conformation during M phase induction.  The 
preliminary data from a previous graduate student in our group, Xi Zhou, showed that 
ALIX transformed from closed conformation to open conformation in mitotic arrested 
HEK293 cells, suggesting that mitotic cells may be a good platform to study the 
possible role of phosphorylation in conformational change of ALIX. 
To test our hypothesis, I designed and performed this part of study. My study 
demonstrates that ALIX phosphorylation at the intramolecular interaction site within the 
nPRD relieves the default intramolecular interaction of cytosolic ALIX in mitotic cells 
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and that this activating phosphorylation of ALIX is required for ALIX to support 
cytokinetic abscission and EIAV budding but does not affect the function of ALIX in 
MVB sorting of activated EGFR.  
 
Results 
4.1. The intramolecular interaction of cytosolic ALIX is relieved in a 
phosphorylation-dependent manner during M phase entry 
To determine whether the intramolecular interaction of ALIX is relieved during M 
phase entry, conformation-sensitive anti-ALIX antibodies were used to 
immunoprecipitate cytosolic ALIX from asynchronously growing (>95% interphase cells) 
or mitotically arrested (>80% mitotic cells) HEK293 cells, which were extracted with the 
cell extraction buffer without detergent. The extraction buffer for mitotically arrested 
cells contains ATP and the PP1/PP2A inhibitor microcystin to stabilize the M phase 
status of the extracts. Immunoprecipitation of asynchronously growing cell lysates (IE) 
or mitotically arrested cell lysates (ME) showed that conformation-sensitive anti-ALIX 
antibodies, 1A3 and 2H12, specifically immunoprecipitated cytosolic ALIX from ME, 
indicating that cytosolic ALIX in ME is in an open conformation. In contrast, 
conformation-insensitive anti-ALIX antibodies, 1A12 and 3A9, immunoprecipitated 
comparable levels of cytosolic ALIX from both IE and ME (Fig. 22A). Immunoblotting of 
IE and ME with the mitotic phosphoprotein monoclonal antibody 2 (MPM-2) (Wu et al., 
2010) showed robust increase of the level of protein phosphorylation in mitotic cells, 
demonstrating the mitotic state of ME. Since the extraction buffer for mitotically 
arrested cells contains ATP and microcystin, there is a possibility that the added ATP 
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and microcystin induce the open conformation of ALIX. To test this possibility, I used 
the extraction buffer containing ATP and microcystin to prepare both IE and ME, and 
performed immunoprecipitation with the 2H12 and 3A9 antibodies. As shown in Fig. 
22B, although the 2H12 antibody immunoprecipitated detectable level of ALIX from IE, 
it immunoprecipitated much higher level of ALIX from ME as did the 3A9 antibody, 
indicating that the conformational change of ALIX in mitotic cells is not due to the buffer 
condition. These results demonstrate that the intramolecular interaction of ALIX is 
relieved to transform ALIX from closed conformation to open conformation during M 
phase induction. 
To further test the conclusion, I examined the interactions between cytosolic 
ALIX and some of its partner proteins, such as CHMP4, TSG101, and Src in IE and ME. 
These interactions are inhibited by the intramolecular interaction of ALIX. Ectopically 
expressing FLAG-CHMP4B or endogenous TSG101 was not co-immunoprecipitated 
with cytosolic ALIX in IE. In contrast, both of them were co-immunoprecipitated with 
cytosolic ALIX in ME (Fig. 22C-D). These results further support the conclusion. 
To determine whether the conformational change of ALIX during M phase entry 
is induced by mitotic phosphorylation, I treated ME with calf intestinal alkaline 
phosphatase (CIP) and examined the effect on ALIX conformational change.  As shown 
in Fig. 22E, the 1A3 antibody specifically immunoprecipitated cytosolic ALIX from ME, 
indicting the open conformation of ALIX in ME. Treatment of ME with CIP eliminated 
the 1A3 immunoprecipitability of ALIX in ME, indicating that mitotic phosphorylation is 
required for conformational change of ALIX. To determine whether the phosphorylation-
induced open conformation of ALIX is reversible event, purified protein GST-CHMP4B 
or in-vitro translated myc-TSG101 was added into ME before CIP treatment, it partially 
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rescued the 1A3 immunoprecipitability of ALIX (Fig. 21F-G), suggesting that partner 
protein interaction partially keeps the open conformation of ALIX. Immunoblotting of IE, 
ME and ME plus CIP with MPM2 demonstrated the mitotic state of ME and the efficacy 
of CIP treatment. 
These results demonstrate that mitotic phosphorylation induces an open 
conformation of ALIX during M phase entry. 
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Figure 22. The intramolecular interaction of cytosolic ALIX is relieved in a 
phosphorylation-dependent manner during M phase entry. (A) IE and ME from 
HEK293 cells were prepared and immunoblotted with MPM-2 and the 3A9 antibody 
(left panel). IE and ME were immunoprecipitated with indicated conformation-sensitive 
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or conformation-insensitive anti-ALIX antibodies followed by immunoblotting. (B) IE and 
ME from HEK293 cells were prepared with the same extraction buffer containing ATP 
and microcystin and immunoblotted with MPM-2 and the 3A9 antibody (left panel). IE 
and ME were immunoprecipitated with indicated conformation-sensitive or 
conformation-insensitive anti-ALIX antibodies followed by immunoblotting. (C&D) IE 
and ME were immunoprecipitated with indicated antibodies, and immunocomplexes 
were immunoblotted to visualize ALIX and FLAG-CHMP4B (C) or ALIX and TSG101 
(D). (E) IE, ME and CIP-treated ME were immunoblotted with MPM-2. (F&G) ME was 
first incubated with GST or GST-CHMP4B (F) or myc or myc-TSG101 (G) at 4ºC for 2 h, 
and then treated with CIP. All the samples were immunoprecipitated with IgG or the 
1A3 antibody followed by immunoblotting. 
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4.2.   Phosphorylation of ALIXnPRD disrupts the interaction between ALIXBro1 and 
ALIXnPRD 
Since the intramolecular interaction of ALIX is achieved between Bro1 domain 
and nPRD (Fig. 23A), the next step is to determine phosphorylation of which domain is 
responsible for relieving the intramolecular interaction. For this purpose, I first treated 
in-vitro translated myc-ALIXnPRD with interphase-arrested Xenopus oocyte extracts 
(IOE), M phase-arrested Xenopus egg extracts (MEE) or MEE plus CIP and then 
incubated the treated myc-ALIXnPRD with immobilized GST-ALIXBro1. Immunoblotting of 
input proteins showed that MEE treatment induced a phosphorylation-dependent gel 
mobility shift. The results of GST pull-down showed that although IOE or MEE plus CIP 
treated myc-ALIXnPRD was pulled down by GST-ALIXBro1, MEE treated myc-ALIXnPRD 
could not be pulled down by GST-ALIXBro1 (Fig. 23B), suggesting that phosphorylation 
of ALIXnPRD by MEE disrupts the interaction between ALIXnPRD and ALIXBro1. Then, I 
treated GST-ALIXBro1 with IOE, MEE, or MEE plus CIP and immobilized treated GST-
ALIXBro1 onto GSH beads. Immunoblotting of washed GST-ALIXBro1 with anti-p-Tyr 
antibody demonstrated that ALIXBro1 was phosphorylated by MEE (Fig. 23C). The 
ability of washed GST-ALIXBro1 to interact with myc-ALIXnPRD was examined by GST 
pull-down. MEE-treated GST-ALIXBro1 still pulled down myc-ALIXnPRD, although its 
ability decreased by ~30% compared to IOE or MEE plus CIP treated GST-ALIXBro1 
(Fig. 23D). The results suggest that phosphorylation of ALIXBro1 by MEE only weakens 
the interaction between ALIXnPRD and ALIXBro1. 
Taken together, these results indicate that phosphorylation of ALIXnPRD plays a 
major role in relieving the intramolecular interaction of ALIX. 
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Figure 23. Phosphorylation of ALIXnPRD disrupts the interaction between ALIXBro1 
and ALIXnPRD. (A) Schematic illustration of ALIX and ALIX fragments used in this study. 
(B) The in vitro translated myc-ALIXnPRD was incubated with IOE, MEE, or MEE plus 
CIP. GST pull-down was used to examine the interaction between treated myc-
ALIXnPRD and immobilized GST-ALIXBro1. Input of the treated myc-ALIXnPRD was 
immunoblotted; the gel mobility shift of treated myc-ALIXnPRD was indicated (left panel); 
bound proteins from GST pull-down were immunoblotted (right panel). (C) GST or 
GST-ALIXBro1 was first incubated with IOE, MEE, or MEE plus CIP, and immobilized 
onto GSH beads. The beads was washed and immunoblotted with an anti-
phosphotyrosine (p-Tyr) antibody. (D) GST or GST-ALIXBro1 was first incubated with 
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IOE, MEE, or MEE plus CIP, and then immunoblized onto GSH beads. The beads were 
washed and then incubated with in-vitro translated myc-ALIXnPRD. GST pull-down was 
used to examine the interaction between treated myc-ALIXnPRD and myc-ALIXnPRD (left 
panel). The level of myc-ALIXnPRD pulled down by treated GST-ALIXBro1 was quantified 
and plotted (right panel). 
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4.3.  Phosphorylation of both S718 and S721 residues disrupts the interaction 
between ALIXnPRD and ALIXBro1 
Since the studies above demonstrate that phosphorylation of ALIXnPRD makes 
major contribution to disrupting the intramolecular interaction, I focused on ALIXnPRD in 
the following studies. Sequence alignment of ALIXnPRD and Xp95nPRD showed that two 
conserved residues, Ser718 (S718) and Ser721 (S721) in ALIXnPRD, locate at one of 
the intramolecular interaction site (residues 717-720: PSAP) (Fig. 24A). Since 
phosphorylation may disrupt the protein interaction, I hypothesized that phosphorylation 
at the S718 and S721 residues may be responsible for disrupting the interaction 
between ALIXBro1 and ALIXnPRD. To test this hypothesis, I first examined whether these 
two residues in ALIXnPRD are phosphorylated in our in-vitro experimental system.  
For this purpose, phospho-specific antibodies that recognize the phosphorylated 
S718 and S721 residues were needed. First, we found that the Phospho-(Ser/Thr) PKD 
Substrate Antibody from Cell Signaling Technology (Catalog number: #4381) detects 
peptides and proteins containing a phospho-S/T residue with arginine at the -3 position 
and leucine at the -5 position, preferring proline at the -1 position. Since the S718 
context fits these criteria, the #4381 antibody was used to determine whether the S718 
residue in ALIXnPRD is phosphorylated by MEE treatment. We also produced rabbit 
polyclonal antibodies against a synthetic ALIX peptide that is phosphorylated at both 
S718 and S721 residues. The antibody, which was named as anti-pS2 antibody, was 
also used in the following studies.   
As shown in Fig. 24B, the #4381 antibody recognized MEE-treated WT GST-
ALIXnPRD, but not mock-treated WT GST-ALIXnPRD or MEE-treated phosphodefective 
S718A-S721A (S2A) mutant form GST-ALIXnPRD. Immunoprecipitation with the #4381 
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antibody showed that the #4381 antibody specifically immunoprecipitated MEE-treated 
WT myc-ALIXnPRD, but not mock-treated WT myc-ALIXnPRD or MEE-treated S2A myc-
ALIXnPRD. These results suggest that the S718 residue in ALIXnPRD is phosphorylated 
by MEE treatment. As shown in Fig. 24C, the anti-pS2 antibody specifically recognized 
MEE-treated GST-ALIXnPRD, and also specifically immunoprecipitated MEE-treated 
myc-ALIXnPRD. These results further demonstrate that the S718 and S721 residues in 
ALIXnPRD are phosphorylated by MEE treatment. 
To determine whether phosphorylation at the S718 and S721 residues by MEE 
disrupts the interaction between ALIXnPRD and ALIXBro1, I further made constructs of 
myc-ALIXnPRD containing phosphomimetic mutations at the S718 and S721 residues 
(S718D-S721D, S2D) or phosphodefective mutations at the adjacent residues S712 
and S729 (S712A-S729A, S2A-). The S2A, S2D or S2A- myc-ALIXnPRD was treated 
with IOE, MEE or MEE plus CIP and pulled down by GST-ALIXBro1. As shown in Fig. 
24D, GST-ALIXBro1 pulled down S2A myc-ALIXnPRD under all three conditions, pulled 
down S2A- myc-ALIXnPRD only upon treatment with IOE or MEE plus CIP but did not 
pull down S2D myc-ALIXnPRD under any of the conditions. These results suggest that 
phosphorylation at the S718 and S721 residues are required to disrupt the interaction 
between ALIXBro1 and ALIXnPRD. 
To further determine whether the disruption of the interaction between ALIXBro1 
and ALIXnPRD is a direct effect from phosphorylation or an indirect effect from 
phosphorylation-dependent recruitment of cofactors, I examined this interaction by 
using GST pull-down in the absence of any treatment. As shown in Fig. 24E, GST-
ALIXBro1 pulled down comparable levels of WT, S2A or S2A- myc-ALIXnPRD, but an 
undetectable level of S2D myc-ALIXnPRD. The results indicate that phosphorylation at 
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S718 and S721 residues directly disrupts the interaction between ALIXBro1 and 
ALIXnPRD. 
The S718 residue localizes in a context that fits the phosphorylation consensus 
sequences for PLK1 and PKD. To determine whether PLK1 and PKD, both of which 
are active in mitosis (Golsteyn et al., 1995; Kienzle et al., 2013), are responsible for 
phosphorylating the S718 and S721 residues, I pre-treated MEE with DMSO, PKD 
inhibitor CID755673, PLK1 inhibitor BI-2536, combination of both inhibitors, and pan-
kinase inhibitor staurosporine. Then, the treated MEE was used to phosphorylate GST-
ALIXnPRD in the presence of these inhibitors. Immunoblotting with the anti-pS2 antibody 
showed that the pan kinase inhibitor significantly inhibited the phosphorylation of GST-
ALIXnPRD. However, the PKD and PLK1 inhibitors only reduced the phosphorylation of 
GST-ALIXnPRD by ~17% and ~35%, respectively, and together reduced the 
phosphorylation by ~41% (Fig. 24F).  These results suggest that PLK1 and PKD are 
among the multiple kinases in MEE that phosphorylate the S718 and S721 residues in 
ALIXnPRD. 
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Figure 24. Phosphorylation of both S718 and S721 residues disrupts the 
interaction between ALIXnPRD and ALIXBro1.  (A) Sequence alignment of ALIXnPRD 
and Xp95nPRD; conserved S/T residues are highlighted. (B) WT and S2A GST-ALIXnPRD 
were mock treated or incubated with MEE and immobilized onto GSH beads. The 
beads were washed and immunoblotted with the #4381 antibody (left panel). In-vitro 
translated myc-ALIXnPRD was mock-treated or incubated with MEE. The treated myc-
ALIXnPRD was immunoprecipitated under denaturing condition (dIP) with the #4381 
antibody followed by immunoblotting (right panel). (C) WT and S2A GST-ALIXnPRD were 
mock treated or incubated with MEE and immobilized onto GSH beads. The beads 
were washed and immunoblotted with the anti-pS2 antibody (left panle). In-vitro 
translated myc-ALIXnPRD was mock-treated or incubated with MEE. The treated myc-
ALIXnPRD was immunoprecipitated under denaturing condition (dIP) with the anti-pS2 
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antibody followed by immunoblotting (right panel). (D) In vitro translated products of 
indicated forms of myc-ALIXnPRD were incubated with IOE, MEE, or MEE plus CIP, and 
immunoblotted with anti-myc antibodies (left panel). The interaction between treated 
myc-ALIXnPRD and GST-ALIXBro1 was examined by GST pull-down (right panel). (E) In 
vitro translated products of indicated forms of myc-ALIXnPRD were incubated with 
immobilized GST or GST-ALIXBro1. Input and pull-down proteins were immunoblotted. 
(F) GST-ALIXnPRD was mock treated or incubated with MEE in the presence or absence 
of PKD inhibitor CID755673 (CID), PLK1 inhibitor BI-2536 (BI), both inhibitors (C+B) or 
pan-kinase inhibitor staurosporine (ST). Then, the treated GST-ALIXnPRD was 
immobilized onto GSH beads, which was washed after binding, and immunoblotted 
with the anti-pS2 antibody (left panel). Relative levels of phosphorylated GST-ALIXnPRD 
were determined and normalized against the level of total GST-ALIXnPRD (right panel).  
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4.4.  Phosphorylation of both S718 and S721 residues transforms ALIX from 
close conformation to open conformation in mitotic cells 
To determine whether the S718 and S721 residues are also phosphorylated in 
mitotic cells, I first performed denaturing immunoprecipitation (dIP) of IE and ME by 
using the #4381 antibody. The results showed that the #4381 antibody specifically 
immunoprecipitated ALIX from ME, indicating that the S718 residue is phosphorylated 
in mitotic cells. Then, I performed dIP of IE and ME by using the 3A9 antibody followed 
by immunoblotting of immunocomplex with the anti-pS2 antibody. The results showed 
that the anti-pS2 antibody specifically recognized ALIX in ME, indicating that both S718 
and S721 residues are phosphorylated in mitotic cells (Fig. 25A).  
To determine whether the recognition by two phospho-specific antibodies is due 
to the phosphorylation at the S718 and S721 residues, I transfected HEK293 cells with 
WT or S2A GFP-ALIX and performed dIP of IE and ME by using the #4381 antibody. 
The results showed that the #4381 antibody specifically immunoprecipitated WT GFP-
ALIX from ME, but not IE. The #4381 antibody did not immunoprecipitate S2A GFP-
ALIX from either IE or ME.  The dIP of IE and ME was also performed by using anti-
GFP antibody followed by immunoblotting of immunocomplex with the anti-pS2 
antibody. The results showed that the anti-pS2 antibody specifically recognized WT 
GFP-ALIX from ME, but not IE. Similar to the #4381 antibody, the anti-pS2 antibody 
also did not recognize S2A GFP-ALIX from either IE or ME (Fig. 25B-C). The results 
further demonstrate that the S718 and S721 residues are phosphorylated in mitotic 
cells.  
To determine whether phosphorylation at the S718 and S721 residues are 
responsible for relieving the intramolecular interaction of ALIX in mitotic cells, I 
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transfected HEK293 cells with WT, S2A, S2D or S2A- GFP-ALIX and performed 
immunoprecipitation of IE and ME with the 2H12 and 3A9 antibodies. As shown in Fig. 
25D, the 2H12 antibody only immunoprecipitated S2D GFP-ALIX from IE, indicating 
that only S2D GFP-ALIX is in the open conformation in IE. The 2H12 antibody 
immunoprecipitated WT, S2D and S2A- GFP-ALIX from ME. In contrast, the 2H12 
antibody did not immunoprecipitate S2A GFP-ALIX from either IE or ME, indicating that 
S2A GFP-ALIX could not transform to the open conformation in mitotic cells. The 2H12-
immnuprecipitable GFP-ALIX was also co-immunoprecipitated with CHMP4B and 
TSG101. These results demonstrate that phosphorylation at the S718 and S721 
residues are responsible for relieving the intramolecular interaction of ALIX and 
inducing the open conformation of ALIX in mitotic cells. 
To determine whether phosphorylation at both residues are required for relieving 
the intramolecular interaction of ALIX, I transfected HEK293 cells with WT, S718A, 
S721A or S2A GFP-ALIX and performed immunoprecipitation of ME with the 2H12 and 
3A9 antibodies. As shown in Fig. 25E, the levels of S718A GFP-ALIX and S721A GFP-
ALIX immunoprecipitated by the 2H12 antibody are ~40% and ~70% of the level of WT 
GFP-ALIX immunoprecipitated by the 2H12 antibody. These results suggest that 
complete relieve of the intramolecular interaction of ALIX requires phosphorylation at 
both S718 and S721 residues. Co-IP results showed that mutations at S718 and S721 
residues did not affect ALIX interaction with TSG101 (Fig. 25F). 
To determine whether PLK1 or/and PKD are also responsible for 
phosphorylating the S718 and S721 residues in mitotic cells, HEK293 cells were 
synchronized in mitosis in the presence or absence of the PLK1 inhibitor and/or the 
PKD inhibitor, or the pan kinase inhibitor, and determined the phosphorylation  of ALIX 
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with the anti-pS2 antibody. As shown in Fig. 25G-H, the immunoblotting of the whole 
cell lysates with MPM-2 showed that only the pan kinase inhibitor inhibited mitotic entry. 
The PKD inhibitor inhibited the phosphorylation of the S718 and S721 residues in ALIX 
by ~15%, the PLK1 inhibitor inhibited the phosphorylation by ~25% and the 
combination of two inhibitors inhibited the phosphorylation by ~39%. As anticipated, the 
pan kinase inhibitor completely inhibited the phosphorylation. These results suggest 
that PKD and PLK1 are among the multiple protein kinases that phosphorylate the 
S718 and S721 residues in ALIX in mitotic cells.  
Taken together, these results demonstrate that the phosphorylation at the 718 
and S721 residues in mitotic cells completely relieves the intramolecular interaction of 
ALIX.  
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Figure 25. Phosphorylation of both S718 and S721 residues transforms ALIX 
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from close conformation to open conformation in mitotic cells. (A) IE and ME from 
HEK293 cells were immunoblotted with MPM2 (left panel). IE and ME were 
immunoprecipitated under denaturing condition (dIP) with the #4381 antibody followed 
by immunoblotting (middle panel). IE and ME were immunoprecipitated under 
denaturing condition (dIP) with the 3A9 antibody followed by immunoblotting with the 
3A9 antibody and anti-pS2 antibody (right panel). (B&C) HEK 293 cells were 
transfected with WT or S2A GFP-ALIX. IE and ME from these transfected cells were 
immunoprecipitated under denaturing condition (dIP) with the #4381 antibody followed 
by immunoblotting with an anti-GFP antibody (B), or with an anti-GFP antibody followed 
by immunoblotting with an anti-GFP antibody and the anti-pS2 antibody (C). (D) 
HEK293 cells were transfected with WT or indicated mutant forms of GFP-ALIX.  IE 
and ME these transfected cells were immunoblotted with indicated antibodies or 
immunoprecipitated with indicated anti-ALIX antibodies followed by immunoblotting. (E) 
HEK293 cells were transfected with WT or indicated mutant forms of GFP-ALIX. IE and 
ME from these transfected cells were immunoprecipitated with indicated anti-ALIX 
antibodies. Input proteins and immunocomplexes were immunoblotted with an anti-
GFP antibody. (F) HEK293 cells were co-transfected FLAG-TSG101 and GFP, WT, 
S2A, or S2D GFP-ALIX. IE from these transfected cells were immunoprecipitated with 
anti-FLAG antibodies in the presence of 1% Triton X-100. Input proteins and 
immunocomplexes were immunoblotted. (G&H) HEK293 cells were cultured in the 
presence of 2.5 mM TdR for 16 h. The cells were either cultured in the continued 
presence of TdR or in the presence of 100 ng/ml nocodazole (NC). At 5-6 h after NC 
block, when most of cells had not entered mitosis, DMSO, CID (3 µM), BI (100 nM), 
both inhibitors (CID+BI: 3 µM+100 nM) or ST (50 nM) were added to the culture 
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medium, and cells were further cultured for 2-3 h to be accumulated in mitosis. IE and 
ME from collected cells were immunoblotted with MPM2 (G) or immunoprecipitated 
under denaturing condition with the 3A9 antibody followed by immunoblotting with the 
3A9 antibody and anti-pS2 antibody. Relative levels of the phosphorylated ALIX were 
determined and normalized against the levels of total ALIX (H). 
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4.5.  The activating phosphorylation of ALIX is required for ALIX to recruit 
CHMP4 to the midbody 
ALIX has been demonstrated to be critically involved in ESCRT-mediated 
cytokinetic abscission. During cytokinetic abscission, ALIX and TSG101 were recruited 
to the midbody through direct interaction with Cep55. ALIX and TSG101 promoted 
ESCRT-III assembly at the midbody through recruiting CHMP4 (Carlton et al., 2008). 
Since the intramolecular interaction of ALIX prohibits ALIX interaction with CHMP4, I 
hypothesized that phosphorylation at the S718 and S721 residues that relieves the 
intramolecular interaction of ALIX is required for ALIX to support cytokinetic abscission. 
To test this hypothesis, I first determined whether ALIX is required for CHMP4 or 
TSG101 recruitment to the midbody. For this purpose, the ALIX knockdown HeLa cells 
were transfected with mCherry-CHMP4B or mCherry-TSG101, fixed and stained with 
anti-tubulin antibody. As shown in Fig. 26A, knockdown of ALIX inhibited the midbody 
localization of mCherry-CHMP4B in ~70% of the midbody-stage cells examined. In 
contrast, knockdown of ALIX did not affect the midbody localization of mCherry-
TSG101 (Fig. 26B). These results suggest that ALIX is important for the midbody 
localization of CHMP4.  
To further determine the role of the activating phosphorylation of ALIX in 
recruiting CHMP4 to the midbody, I ectopically expressed WT, S2A, or S2A- GFP-
ALIX* in the ALIX knockdown HeLa cells and examined the effects on the midbody 
localization of mCherry-CHMP4B. As shown in Fig. 26C, although WT or S2A- GFP-
ALIX* rescued the midbody localization of mCherry-CHMP4B to the near control level, 
S2A GFP-ALIX* did not have the rescuing effects. These results suggest that the 
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phosphorylation at the S718 and S721 residues are required for ALIX to recruit CHMP4 
to the midbody.  
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Figure 26. The activating phosphorylation of ALIX is required for ALIX to recruit 
CHMP4 to the midbody. (A&B) HeLa cells were transfected with mCherry-CHMP4B 
(A) or mCherry-TSG101 (B), fixed and stained with anti-tubulin antibody (green).  Cell 
110 
 
lysates were immunoblotted to visualize ALIX, mCherry-CHMP4b (A), mCherry-
TSG101 (B) and actin (left panel). The average percentages of mCherry positive cells 
with midbody localization of mCherry-CHMP4b and SDs (A) or mCherry-TSG101 (B) 
were determined from three independent experiments and plotted (left panel). 
Representative images are shown with the squares showing the 5× enlarged midbody 
areas. Solid and hollow arrowheads indicate the presence and absence of mCherry-
CHMP4b (A) or mCherry-TSG101 (B) at the midbody, respectively. Scale bar: 50 µm. 
(C) HeLa cells were transfected with indicated siRNAs for 72 h, and cell lysates were 
immunoblotted with indicated antibodies to visualize ALIX and actin. Fixed cells were 
immunostained with an anti-tubulin antibody (red), and counterstained with DAPI (blue). 
The average percentages of midbody-stage cells or multinucleated cells and SDs were 
determined from three independent experiments and plotted. Representative images 
are shown with solid and hollow arrows indicating mononucleated and multinucleated 
cells, respectively, and hollow arrowheads indicating midbodies between daughter cells. 
Scale bar: 50 µm.  
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4.6.  The activating phosphorylation of ALIX is required for ALIX to support 
cytokinetic abscission 
The midbody localization of CHMP4 is essential for cytokinetic abscission. Thus, 
I then determined whether the activating phosphorylation of ALIX is required for 
cytokinetic abscission. As shown in Fig. 27, knockdown of ALIX in HeLa cells increased 
the percentages of midbody-stage and multinucleated cells from <2% to ~14% and 
~17%, respectively. Ectopic expressing WT, S2A or S2A- GFP-ALIX* localized at the 
midbody in the ALIX knockdown cells. Although WT or S2A- GFP-ALIX* rescued the 
percentages of midbody-stage and multinucleated cells to the near control levels, S2A 
GFP-ALIX* did not have the rescuing effects. These results demonstrate that the 
phosphorylation at the S718 and S721 residues are important for ALIX to support 
cytokinetic abscission.  
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Figure 27. The activating phosphorylation of ALIX is required for ALIX to support 
cytokinetic abscission. HeLa cells were transfected with indicated siRNAs for 48 h 
and then transfected with indicated constructs for 24 h before fixation. The fixed cells 
were stained with an anti-tubulin antibody (red). Cell lysates were immunoblotted to 
visualize GFP-ALIX, ALIX and actin (left panel). The percentages of GFP-positive 
midbody-stage cells and multinucleated cells were scored and plotted (left panel). 
Representative images are shown with solid and hollow arrows indicating GFP-positive 
mononucleated and multinucleated/midbody-stage cells, respectively. Scale bar: 50 µM.  
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4.7.   The activating phosphorylation of ALIX is required for ALIX to support EIAV 
budding 
ALIX has been demonstrated to be critically involved in ESCRT-mediated EIAV 
budding, which is a model system for studying of retroviral budding. ALIX involvement 
in EIAV budding requires ALIX interaction with p9GAG and CHMP4 (Strack et al., 2003). 
Thus, I hypothesized that the activating phosphorylation of ALIX is important for it to 
support EIAV budding.  
To test this hypothesis, I first confirmed the previous reports that ALIX 
interaction with p9GAG needs opened ALIX by showing that GST-p9GAG specifically 
pulled down ALIX from ME, but not IE (Fig. 28A). Moreover, p9GAG interaction with 
opened ALIX could partially keep the open conformation of ALIX even after 
dephosphorylation of ALIX (Fig. 28B). 
To determine whether there is a conformational change of ALIX during EIAV 
budding, HEK293 cells were co-transfected with an infection-defective EIAV Gag 
(pEV53B-GagEIAV) and WT, S2A or S2A- GFP-ALIX, and the conformation of GFP-
ALIX was examined by immunoprecipitation with the 1A3 antibody. As shown in Fig. 
28C, expression of GagEIAV induced 1A3-immunoprecipitable WT or S2A- GFP-ALIX, 
suggesting that the activating phosphorylation is required for generating opened ALIX 
during EIAV budding.  
To determine whether the activating phosphorylation of ALIX is required for it to 
support EIAV budding, the ALIX knockdown HEK293 cells were co-transfected with 
pEV53B-GagEIAV and WT, S2A, or S2A- GFP-ALIX*, and the levels of VLPs were 
examined by collecting the VLPs through ultracentrifugation of culture medium followed 
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by immunoblotting with anti-CA antibody. As shown in Fig. 28D, knockdown of ALIX 
significantly inhibited the budding VLPs, consistent with the previous studies (Strack et 
al., 2003; von Schwedler et al., 2003). Ectopic expression of WT or S2A- GFP-ALIX*, 
but not S2A GFP-ALIX, rescued the defect in EIAV budding, suggesting that the 
phosphorylation at S718 and S721 residues are important for ALIX to support EIAV 
budding. Further studies showed that arresting cells in mitosis blocked EIAV budding 
and that arresting cells in interphase did not affect EIAV budding (Fig. 28E), suggesting 
that EIAV budding only happens in interphase.  
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Figure 28. The activating phosphorylation of ALIX is required for ALIX to support 
EIAV budding. (A) GST or GST-p9 was incubated with IE or ME from HEK293 cells. 
Input and bound proteins were immunoblotted to visualize ALIX, GST and GST-p9. (B) 
ME from HEK293 cells was incubated with GST or GST-p9 at 4ºC for 2 h, and then 
treated with CIP. The samples were immunoprecipitated with IgG or the 1A3 antibody, 
followed by immunoblotting to visualize ALIX, GST and GST-p9. (C) HEK293 cells 
were co-transfected with pEV53B EIAVGag and indicated forms of GFP-ALIX. IE from 
the transfected cells were immunoprecipitated with indicated anti-ALIX antibodies. Input 
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and immunocomplexes were immunoblotted to visualize GFP-ALIX, Gag and actin. (D-
F) HEK293 cells were processed as diagrammed. VLPs and cell lysates were 
immunoblotted with indicated antibodies. Relative levels of VLPs production and SDs 
were determined from three independent experiments and plotted.  
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4.8.    The activating phosphorylation of ALIX is not important for ALIX to support 
MVB sorting of activated EGFR 
ALIX has been demonstrated to be critically involved in ESCRT-III mediated 
MVB sorting of activated EGFR. Calcium-dependent ALG-2 interaction with ALIX 
activates the MVB sorting function of ALIX through relieving its intramolecular 
interaction.  To determine whether the activating phosphorylation collaborates with 
ALG-2 interaction to promote MVB sorting of activated EGFR, I first examined whether 
the activating phosphorylation is required for EGF-stimulated increase of ALIX 
association with the membrane by using membrane flotation centrifugation. As shown 
in Fig. 29A, EGF stimulation increased the percentage of membrane associated WT or 
S2A GFP-ALIX from ~10% to ~30%. In contrast, the membrane association of ∆PxY 
GFP-ALIX is dramatically decreased irrespective of EGF stimulation. These results 
suggest that the activating phosphorylation is not important for EGF-stimulated ALIX 
association with the membrane. 
I then determined whether the activating phosphorylation is required for ALIX to 
promote MVB sorting of activated EGFR by using proteinase K protection assay. As 
shown in Fig. 29B, after 30 min of EGF stimulation, the percentage of protected EGFR 
is ~60%, indicating that ~60% of EGFR was sorted into the lumen of MVB. Knockdown 
of ALIX decreased the percentage of protected EGFR from ~60% to ~15%. WT, S2A or 
S2A- GFP-ALIX similarly rescued the protected percentage of EGFR to the near control 
level, suggesting that the activating phosphorylation is not important for ALIX to support 
MVB sorting of activated EGFR.  Further, I determined the effects of the activating 
phosphorylation on the downstream signaling of activated EGFR by examining the 
levels of EGF-stimulated p-ERK1/2. As shown in Fig. 29C-D, knockdown of ALIX 
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prolonged the duration of p-ERK1/2 from 10 min to 60 min. WT or S2A GFP-ALIX* 
rescued the effect of ALIX knockdown, reducing the duration of p-ERK1/2 to 10 min. 
These results support our conclusion.  
Finally, I determined the effects of the activating phosphorylation on EGF-
induced EGFR degradation under EGF continuous stimulation condition. As shown in 
Fig. 29E-F, knockdown of ALIX retarded the 50% EGFR degradation from 1 h to 2 h. 
Although ∆PxY GFP-ALIX* did not rescue the retardation effect of ALIX knockdown on 
EGFR degradation, WT or S2A GFP-ALIX* could rescue the retardation effect, 
indicating that the activation phosphorylation of ALIX is not important for ALIX to 
function in the degradation of activated EGFR.  
Taken together, these results demonstrate that the phosphorylation at S718 and 
S721 residues is not important for ALIX to support MVB sorting of activated EGFR.  
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Figure 29. The activating phosphorylation of ALIX is not important for ALIX to 
support MVB sorting of activated EGFR. (A) HEK293 cells were transfected with 
indicated forms of GFP-ALIX and stimulated with or without EGF for 1 h. PNSs were 
fractionated by membrane flotation centrifugation. M and S fractions was determined by 
immunoblotting with an anti-GFP antibody. The average percentage of each GFP-ALIX 
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in the M fraction and SDs was determined and plotted. (B-F) HEK293 cells were 
transfected and serum-starved as diagrammed. (B) These cells were stimulated with 
EGF for 30 min before being assayed by the proteinase K protection assay. The 
average percentages of proteinase K-insensitive EGFR were determined and plotted. 
Error bars indicate the range of the data. (C&D) Cells were stimulated with EGF for 
indicated minutes, and cell lysates were immunoblotted to visualize p-ERK, ERK, GFP-
ALIX and ALIX. The relative levels of p-ERK at different time points were determined 
and normalized against the level of si-NC cells at 60 min. (E&F) Cells were stimulated 
with EGF for indicated hours, and cell lysates were immunoblotted to visualize EGFR, 
GFP-ALIX, ALIX and actin. The percentages of remaining EGFR at different time points 
were determined and plotted. 
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Discussion 
My results show that ALG-2 is not important for ALIX-mediated cytokinetic 
abscission or retroviral budding, suggesting that different mechanisms are required to 
activate ALIX in these two processes. Using mitotic cells as the platform, I discovered 
that phosphorylation of the S718 and S721 residues at or near the intramolecular 
interaction site within the nPRD of ALIX in mitotic cells relieves the intramolecular 
interaction of ALIX and that multiple protein kinases, including PLK1 and PKD, are 
responsible for this activating phosphorylation. The functional studies demonstrate that 
this activating phosphorylation is required for ALIX to support cytokinetic abscission 
and retroviral budding, but is not important for MVB sorting of activated EGFR.  
Cytokinetic abscission happens in early interphase when most of the mitotic 
kinases have been inactivated. How the mitotic phosphorylation-induced open 
conformation of ALIX can be maintained in interphase to support cytokinetic abscission? 
There are two possible explanations. One is that multiple mitotic kinase and 
phosphoproteins remain active at the midbody after mitotic exist. For example, the 
midbody was specifically recognized by the mitotic phosphoprotein monoclonal 
antibody MPM-2 (Sun et al., 2016; Vandre et al., 1986), by antibodies that recognize 
activated MEK, ERK and RSK (Sun et al., 2016; Willard and Crouch, 2001), by 
antibodies that recognize aurora B (Crosio et al., 2002; Sun et al., 2016), and by 
antibodies that recognize citron kinase and its activator RhoA (Madaule et al., 1998; 
Sun et al., 2016). Thus, it is possible that some of the kinases that catalyze the 
activating phosphorylation of ALIX in mitotic cells localize and remain active at the 
midbody and continue to catalyze the activating phosphorylation of ALIX. My results 
indicate that PLK1 and PKD are among the multiple mitotic kinases that catalyze the 
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activating phosphorylation of ALIX. Phosphorylation of Cep55 by PLK1 inhibits 
recruitment of Cep55 to the midbody (Bastos and Barr, 2010), making PLK1 less likely 
to be the candidate. However, immunostaining with anti-PKD substrate antibodies 
showed that the staining is barely detectable in interphase, very high and widespread in 
metaphase, decreased and concentrated in the spindle pole and midzone in anaphase 
and early telophase, and specifically lingered in the midbody area in late telophase and 
the midbody stage after most of the staining disappeared. There also may be 
unidentified kinases that remain active in the midbody area. The other explanation is 
that opened ALIX recruits CHMP4 and interacts with TSG101 and that the occupation 
of these partner proteins keeps the open conformation of ALIX even if ALIX is 
dephosphorylated at the midbody. My results indicate that increased occupation by 
partner proteins partially maintain the open conformation of ALIX. These two 
mechanisms may function together to keep a pool of opened ALIX in the midbody area 
to support cytokinetic abscission. The failure of cytokinetic abscission induces 
multinucleated cell. Proliferating multinucleated cells are genetically unstable and can 
promote tumorigenesis. 
Retroviral budding does not expect to happen in mitosis; actually, if the cells are 
arrested in mitosis, the retroviral budding is significantly inhibited. Then, how 
phosphorylation at the S718 and S721 residues affects retroviral budding? There are 
two possible explanations. One possibility is that the infection of retrovirus induces the 
activity of certain kinases that catalyze the phosphorylation of ALIX. However, I could 
not detect the signal of phosphorylation by using the #4381 antibody or anti-pS2 
antibody, suggesting that either the infection does not induce kinase activity or the level 
of phosphorylation is too low to be detected by our antibodies. The other possibility is 
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that the high level of p9GAG in EIAV expressing cells may occupy the opened ALIX and 
keep its open conformation. My results demonstrate that GST-p9GAG interacts with 
opened ALIX and partially keeps the open conformation of ALIX even after 
dephosphorylation of ALIX. Thus, these two mechanisms may function together to 
generate ALIX in open conformation to support retroviral budding.  
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Chapter 5: Discussion, perspective and future directions 
5.1.    The regulation of ALIX in ESCRT-mediated processes 
ALIX is involved in numerous ESCRT-mediated membrane remolding processes, 
including MVB sorting, cytokinetic abscission, retroviral budding, plasma membrane 
wound repair, exosome biogenesis, autophagy and nuclear envelope reformation, and 
all these processes are fundamental cellular processes that are critically involved in cell 
growth and survival (Bissig and Gruenberg, 2014; Hurley, 2015). Although much 
advancement has been made in discovery of key factors in these multi-step processes, 
the regulatory mechanism that links the initiator and the executor of this cascade is still 
poorly understood. ALIX is an essential mediator for linking the upstream initiator and 
the downstream executor of ESCRT-mediated processes by direct interaction with 
cargo proteins and CHMP4. Since CHMP4 interaction is inhibited by the default 
intramolecular interaction of ALIX, the regulation of ALIX in ESCRT-mediated 
processes is a very important question that should be explored for better understanding 
of these essential cellular processes. For investigating the regulation of ALIX in 
ESCRT-mediated processes, I chose the three classical ESCRT-mediated processes 
as the model systems because these three classical ESCRT-mediated processes are 
the most fundamental ones and the mechanisms underlining these processes are well 
studied.   
Three potential mechanisms that relieve the intramolecular interaction have 
been proposed in previous studies from our group (Zhou et al., 2010). One is partner 
protein interaction-induced conformational change; another one is competitive binding-
induced disruption of intramolecular interaction; the third one is posttranslational 
modification-induced disruption of intramolecular interaction. 
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My studies demonstrate that calcium-dependent ALG-2 interaction with ALIX 
specifically activates MVB sorting function of ALIX and that phosphorylation at the 
S718 and S721 residues in the nPRD specifically activates the function of ALIX to 
support cytokinetic abscission and retroviral budding (Fig. 30).   
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Figure 30. Graphic abstract illustrating the mechanisms that activate ESCRT 
functions of ALIX in three classical ESCRT-mediated processes (Sun et al., 2016). 
(Permission obtained from Cell Press, License No.: 3830440570477) 
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5.2. The implication of the two regulatory mechanisms in ESCRT-mediated 
processes 
Since ALG-2 interaction with ALIX is calcium dependent (Missotten MTrioulier et 
al., 2004; Shibata et al., 2004), it is possible that the ESCRT-mediated processes that 
induce calcium spike will activate ALIX through this mechanism. In my current study, 
endocytosis-induced calcium spike promotes ALG-2-mediated activation of ALIX in 
MVB sorting of activated EGFR. Plasma membrane damage also induces calcium 
spike near the damaged site. ALG-2 is important for recruiting ALIX and ESCRT-III to 
the damaged site for repair (Jimenez et al., 2014; Scheffer et al., 2014). Exosome 
biogenesis and autophagosome formation share the similar mechanism for MVB 
sorting, involving sorting cargo proteins into endosome. Thus, calcium-dependent ALG-
2 interaction with ALIX may be also involved in activating ALIX in these processes. 
Phosphorylation-dependent activation of ALIX happens when the kinases 
responsible for catalyzing this phosphorylation are active. Thus, it is possible that 
ESCRT-mediated processes that induce the activities of those responsible kinases will 
activate ALIX through this mechanism. In my current studies, in mitotic cells, which 
have numerous mitotic kinases activated, S718 and S721 residues can be 
phosphorylated by some of these kinases. Partner protein occupation maintains the 
open conformation of ALIX during cytokinetic abscission, which actually happens in 
interphase. Retroviral infection may induce a very low level of phosphorylation at S718 
and S721 residues, even falling below our antibody detection range, through either 
inducing a very low level of kinase activity or utilizing the basal level of kinase activity. 
Low level of phosphorylation may cooperate with partner protein (p6/p9) occupation to 
generate a pool of ALIX in open conformation to support retroviral budding. Proper and 
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timely nuclear envelope reformation prevents DNA damage and protects genomic 
stability (Olmos et al., 2015; Vietri et al., 2015). Recent studies showing that Aurora B 
and ULK3 (Unc-51-like kinase 3)-mediated phosphorylation of CHMP4 delayed 
cytokinetic abscission through inducing defective ESCRT-III polymerization (Caballe et 
al., 2015; Carlton et al., 2012) suggest that phosphorylation-dependent regulation may 
be involved in protecting genomic stability and preventing DNA damage. Thus, in the 
process of ESCRT-mediated nuclear envelope reformation, which may induce activities 
of many kinases, ALIX may be activated in a phosphorylation-dependent manner.  
Thus, my studies of regulation of ALIX in the three classical ESCRT-mediated 
processes provide perspective into the regulation of all ESCRT-mediated membrane 
remolding processes. 
5.3.    The implication of ALG-2/ALIX supported MVB sorting in cancer  
Based on my studies demonstrating the essential role of ALG-2/ALIX-supported 
MVB sorting in silencing of activated EGFR, an interesting question would be: whether 
ALG-2/ALIX-supported MVB sorting also regulate other receptor tyrosine kinases or 
other types of membrane receptors?  Recent studies demonstrated the essential role of 
ALIX in MVB sorting of PAR1, a GPCR family member (Dores et al., 2012a). Although 
involvement of ALG-2 was not examined in that study, it is reasonable to expect that 
ALG-2 is involved in activating ALIX in this process.  
In the absence of normal ESCRT function, the signaling of EGFR and other 
receptor tyrosine kinases, including Insulin receptor, platelet-derived growth factor 
receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR) are 
elevated (Engedal and Mills, 2014; Rodahl et al., 2009; Wegner et al., 2011), indicating 
that MVB sorting is involved in timely silencing of these receptors. Further studies need 
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to use these receptor tyrosine kinases as the model molecules to examine whether 
ALG-2 is also involved in MVB sorting of other receptor tyrosine kinases.  
Activated receptor tyrosine kinases stimulate cell proliferation and survival, thus 
their signaling should be tightly controlled. ALG-2/ALIX-supported MVB sorting is an 
important negative regulator of the signaling of these receptors. If MVB sorting pathway 
has defects, the signaling of the activated receptors cannot be timely terminated. That 
may induce uncontrolled cell proliferation and tumorigenesis (Bache et al., 2004; 
Rodahl et al., 2009; Wegner et al., 2011).  
My studies provide a novel insight into the over-activation of receptor tyrosine 
kinases in cancer cells and suggest that ALG-2/ALIX axis may be a potential target for 
cancer therapy. 
5.4.   The switch of ALIX between its ESCRT-dependent function and ESCRT-
independent function 
Besides the widespread roles of ALIX in ESCRT-mediated processes, ALIX also 
performs diverse ESCRT-independent cellular processes. ALIX was shown to regulate 
cell adhesion, cell morphology and migration (Pan et al., 2008; Pan et al., 2006; 
Schmidt et al., 2003). These studies indicate that cytosolic ALIX is able to perform 
these functions. My studies demonstrate that cytosolic ALIX is in closed conformation 
and that ALIX in open conformation will associate with membrane. Thus, the possible 
scenario is that ESCRT-dependent functions of ALIX require open conformation of 
ALIX, while ESCRT-independent functions of ALIX need closed conformation of ALIX. 
Then, how ALIX is switched between these two types of functions and its implication in 
cancer is an important and interesting question.  
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The evidence from the studies in our group indicates that the ESCRT-
independent functions of ALIX may promote tumor cell migration. However, if ALIX is 
induced to open conformation, opened ALIX may exert malignancy inhibitory effects 
through promoting MVB sorting and silencing of activated receptor tyrosine kinases. In 
this context, ALG-2 may be an essential factor to regulate the switch of ALIX between 
pro-malignant function and anti-malignant function. 
5.5.    A potential new strategy to target activated receptor tyrosine kinases 
Current therapeutic strategies to target receptor tyrosine kinases in cancer cells 
are either targeting a specific type of receptors by using antibody, inhibiting the activity 
of a specific type of receptors by small-molecule inhibitors or inhibiting the downstream 
signaling of activated receptors by small-molecule inhibitors. The limitation of these 
strategies is that we can only target specific type of receptor tyrosine kinases. Then, 
other receptor tyrosine kinases may play redundant roles to induce drug-resistance.  
If we can develop a compound that can mimic ALG-2/ALIX interaction to induce 
open conformation of ALIX, this compound will promote ALIX-supported MVB sorting 
and silencing of activated receptor tyrosine kinases. The advantage of this strategy is 
that it can target multiple receptor tyrosine kinases simultaneously.  
5.6.     Future directions 
Our current studies also raise multiple new problems that deserve further 
investigations. 
1. To examine whether the regulatory mechanisms identified in the current 
studies also apply to other ESCRT-mediated processes.  
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Besides the three classical ESCRT-mediated processes studied in the current 
research, there are many new identified ESCRT-mediated processes. How these 
ESCRT-mediated processes are regulated is an important and interesting question. By 
using three classical ESCRT-mediated processes, our current studies identified two 
regulatory mechanisms: calcium-dependent ALG-2 interaction and phosphorylation.  
Future studies would test whether either of them applies to new identified ESCRT-
mediated processes. There is possible that some of the ESCRT-mediated processes 
use neither of these two mechanisms. In this case, further studies may be performed to 
explore the novel mechanisms that activate ALIX.  
2. To examine whether ALG-2/ALIX-supported MVB sorting applies to other 
receptor tyrosine kinases. 
EGFR is the model molecule for study of MVB sorting of ubiquitinated receptor 
tyrosine kinases. ALG-2 was identified as apoptosis inducing protein and shown to 
have dysregulation in many types of cancer. ALIX was also initially found to have 
apoptosis inducing effects. Moreover, ALG-2 and ALIX interaction is required for them 
to be involved in inducing apoptosis. However, the underlining mechanism is still not 
clear. The potential role of ALG-2/ALIX-supported MVB sorting in silencing of receptor 
tyrosine kinases is a possible underline mechanism.  Thus, in future studies, we need 
to examine the effects of ALIX or ALG-2 knockdown on downstream signaling and 
degradation of insulin receptor, PDGFR and VEGFR. If positive results are obtained, 
further studies may be performed to examine the role of ALG-2/ALIX-supported MVB 
sorting in cell proliferation, apoptosis and migration.  
3. To identify the kinases responsible for catalyzing the phosphorylation at 
S718 and S721 residues of ALIX. 
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Based on our current studies showing that even combination of PLK1 and PKD 
inhibitors cannot completely inhibit S718-S721 phosphorylation, there are two 
possibilities: one is that PLK1 and PKD are among the multiple kinases that play 
redundant roles in phosphorylating S718-S721 residues; the other possibility is that the 
major kinase(s) that is/are responsible for this activating phosphorylation is still 
unidentified. To test these possibilities, we can use GST-ALIXnPRD to pull down proteins 
from MEE or ME and wash off the binding proteins. These proteins will be analyzed by 
mass spectrometry, which may identify all kinases binding to ALIXnPRD. Then, the 
kinase inhibitors will be used to further test the involvement of these kinases. 
Identifying the responsible kinases will lead to a better understanding for the 
phosphorylation-dependent regulation of ESCRT-mediated processes. 
4. To examine the mechanisms that switch ALIX between non-ESCRT 
function and ESCRT function. 
Our current studies as well as the studies from previous graduate student in our 
group indicated that ESCRT function of ALIX may be involved in malignancy inhibition 
while non-ESCRT function of ALIX may be involved in promoting cell migration. Thus, 
investigating the potential mechanisms that switch ALIX between ESCRT function and 
non-ESCRT function will lead to a better understanding for the role of ALIX in cancer 
biology. We hypothesize that conformational change of ALIX may be the switch. To test 
the hypothesis, we will examine the role of ALIX in cell migration. We will also examine 
the effects of constitutive opened ALIX on cell proliferation, cell morphology and 
apoptosis. Further studies may develop a compound that can induce the open 
conformation of ALIX and examine the malignancy inhibitory effects of the compound.  
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Chapter 6: Experimental procedures 
 
Cell culture, transfection, EGF stimulation and cell synchronization 
HEK293 and HeLa cells were maintained in Dulbecco’s Modification of Eagle’s 
Medium (DMEM) (Mediatech Inc) supplemented with 2 mM L-glutamine and 10% fetal 
bovine serum (Atlanta Biologicals). Subconfluent cultures of cells in 60-mm or 35-mm 
culture dishes were transfected with siRNAs or expression vectors using GenMute™ 
siRNA Transfection Reagent or PolyJet™ DNA In Vitro Transfection Reagent 
(SignaGen Laboratories) according to manufacturer’s instructions. Transfected cells 
were cultured for additional 24 to 48 h before experimental analyses. Transfection with 
ALIX-specific siRNAs was done twice (at 0 and 24 h) as performed in multiple previous 
studies, due to high abundance of ALIX. siRNAs used in this study are summarized in 
Table 2. Mammalian expression vectors used in this study are summarized in Table 3, 
and PCR primers used for site-directed mutagenesis and making vectors are 
summarized in Table 4. 
The calcium ionophore A23187 (Sigma) was solubilized in 0.1% DMSO, and 
was added to the culture medium at a final concentration of 10 µM 15 min before cell 
collection. Cell permeable calcium chelator BAPTA-AM (Toronto Research Chemicals) 
was solubilized in DMSO and added to the culture medium at a final concentration of 
10 µM 1 h before EGF stimulation.  
Subconfluent cells in 35-mm dishes were switched to serum free DMEM medium 
and cultured for ~12 h for serum starvation. For continuous EGF stimulation, 
recombinant EGF (Sigma) was added to the serum free DMEM medium at a final 
concentration of 100 ng/ml, and cells were cultured further for indicated lengths of time. 
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For pulse-chase EGF stimulation, recombinant EGF was added to the serum free 
DMEM medium at a final concentration of 100 ng/ml. Serum-starved cells were first 
incubated with EGF at 4ºC for 30 min (pulse), and then changed to EGF- and serum-
free medium and cultured at 37ºC for indicated lengths of time (chase). The lysosome 
inhibitor chloroquine (CQ) (Sigma) was added to the medium at a final concentration of 
25 mM, whenever indicated. 
To synchronize cells in mitosis, HEK293 cells were first cultured in DMEM 
containing 2.5 mM thymidine (Sigma) for 16 h and cultured in fresh DMEM for 3 h to 
release the cells. Then, 100 ng/mL nocodazole (NC) (Sigma) was added to DMEM for 
mitotic block. To prevent cells into mitosis, HEK293 cells were cultured in DMEM 
containing 2.5 mM thymidine (Sigma) for 16-24 hr to be arrested in S phase. 
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Table 2. Sequences of siRNAs used in this study 
Target Name Sequence Source 
ALIX si-ALIX(1) 5’-GAGAAGAAAUUGCAAGGUUdTdT-3’ Sigma-
Genosys 
ALIX si-ALIX(2) 5’-GAAGGAUGCUUUCGAUAAAdTdT-3’ Sigma-
Genosys 
ALG-2 si-ALG-2(1) 5’-GGUCGAUCAUAUCCAUGUUdTdT-3’ Sigma-
Genosys  
ALG-2 si-ALG-2(2) 5’-GACAGGAGUGGAGUGAUAUdTdT-3’ Sigma-
Genosys 
Firefly 
GL3 
luciferase 
si-NC 5’-CUUACGCUGAGUACUUCGAdTdT-3’ 
 
Sigma-
Genosys 
CHMP4B si-CHMP4B 5’-AGAAGAGUUUGACGAGGAUdTdT-3’ Sigma-
Genosys 
CHMP4B si-CHMP4B 5’-CGGAAGAGAUGUUAACGAAdTdT-3’ Sigma-
Genosys 
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Table 3. Mammalian expression vectors used in this study 
Vector Source 
pEGFP-C3-based expression vector for GFP-ALIX A gift from Dr. Masatoshi 
Maki (Nagoya, Japan) 
(Shibata et al., 2004) 
pEGFP-C3-based expression vector for ALIX-siRNA(1)-
insensitive  GFP-ALIX  
Made in this study 
pEGFP-C3-based expression vector for I212D GFP-
ALIX 
Made in this study 
pEGFP-C3-based expression vector for ALIX-siRNA(1)-
insensitive I212D GFP-ALIX  
Made in this study 
 pEGFP-C3-based mammalian expression vector for 
ΔPxY GFP-ALIX 
A gift from Dr. Masatoshi 
Maki (Nagoya, Japan) 
(Shibata et al., 2004) 
pEGFP-C3-based expression vector for ALIX-siRNA(1)-
insensitive DM GFP-ALIX 
Made in this study 
pEGFP-C3-based mammalian expression vector for 
S718A GFP-ALIX 
Made in this study 
pEGFP-C3-based mammalian expression vector for 
S721A GFP-ALIX 
Made in this study 
pEGFP-C3-based mammalian expression vector for 
S718A-S721A GFP-ALIX 
Made in this study 
pEGFP-C3-based mammalian expression vector for 
S712A-S729A GFP-ALIX 
Made in this study 
pEGFP-C3-based mammalian expression vector for 
S718A-S721A ALIX-siRNA-insensitive GFP-ALIX (S2A 
GFP-ALIX*) 
Made in this study 
pEGFP-C3-based mammalian expression vector for 
S712A-S729A ALIX-siRNA-insensitive GFP-ALIX (S2A- 
GFP-ALIX*) 
Made in this study 
pEGFP-C3-based mammalian expression vector for 
S718D-S721D GFP-ALIX 
Made in this study 
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pCMV-based expression vector for FLAG-CHMP4b A gift from Dr. Masatoshi 
Maki (Nagoya, Japan) 
(Katoh et al., 2003) 
pCMV-Tag2C-based mammalian expression vector for 
FLAG-ALG-2 
A gift from Dr. Changmin 
Chen (Boston, MA) (Chen 
and Sytkowski, 2005) 
pCMV-Tag2C-based mammalian expression vector for 
siRNA(1)-insensitive FLAG-ALG-2 (FLAG-ALG-2*) 
Made in this study 
pCMV-Tag2C-based mammalian expression vector for 
E47A FLAG-ALG-2 
Made in this study 
pCMV-Tag2C-based mammalian expression vector for 
E47A/E114A FLAG-ALG-2  
Made in this study 
pCMV-Tag2C-based mammalian expression vector for 
E47A/E114A FLAG-ALG-2* 
Made in this study 
The pIRES2-based mammalian expression vector for 
FLAG–TSG101 
 
A gift from Dr. Wesley I. 
Sundquist (Salt Lake City, 
UT) (von Schwedler et al., 
2003) 
pEGFP-C3-based mammalian expression vector for 
GFP-Rab5 (Q79L)  
A gift from Jean Gruenberg 
(Geneva, Switzerland) 
(Brankatschk et al., 2012) 
pEV53B-based mammalian expression vector for 
infection defective EIAV 
A gift from Dr. John Olsen 
(Chapel Hill, NC) (Olsen, 
1998) 
 pGEX-4T3 based bacterial expression vector for WT 
GST-ALG-2 
Made in this study 
pGEX-4T3 based bacterial expression vector for 
E47A/E114A GST-ALG-2 
Made in this study 
pGEX-4T3 based bacterial expression vector for 
E47A/E114A GST-ALG-2 
Made in this study 
pGEX-4T3 based bacterial expression vector for GST-
p6HIV-Gag 
A gift from Dr. Wesley I. 
Sundquist  (Salt Lake City, 
UT) (Fisher et al., 2007) 
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pGEX-4T3 based vector bacterial expression for GST-
p9EIAV-Gag 
A gift from Dr. Wesley I. 
Sundquist (Salt Lake City, 
UT) (Fisher et al., 2007) 
pmCherry-C1-based expression 
vector for mCherry-CHMP4b 
Made in this study 
pmCherry-C1-based expression 
vector for mCherry-TSG101 
Made in this study 
pCS2-MT based TNT expression vector for myc-
ALIXnPRD 
Made in this study 
pCS2-MT based TNT expression vector for S718A-
S721A myc-ALIXnPRD 
Made in this study 
pCS2-MT based TNT expression vector for S712A-
S729A myc-ALIXnPRD 
Made in this study 
pCS2-MT based TNT expression vector for S718D-
S721D myc-ALIXnPRD 
Made in this study 
pCS2-MT based TNT expression vector for myc-
TSG101 
Made in this study 
pCS2-HA based expression vector for HA-Plx1 
(Xenopus) 
Made in this study 
pCS2-HA based expression vector for HA-K82R Plx1 
(Xenopus) 
Made in this study 
pGEX-4T3 based bacterial expression vector GST-
ALIXnPRD 
Made in this study 
pGEX-4T3 based bacterial expression vector for GST-
ALIXBro1 
Generated in our previous 
studies (Zhou et al., 2009) 
pGEX-4T3 based bacterial expression vector for GST-
ALIX1-746 
Generated in our previous 
studies (Zhou et al., 2009) 
pGEX-4T3 based bacterial expression vector for GST-
CHMP4b 
Made in this study 
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Table 4. PCR primers used in this study 
Product Primers (Forward/Reverse) 
ALIX-siRNA(1) 
insensitive 
GFP-ALIX  
5’GAAGAAATTTGGAGAGGAAATTGCAAGGTTAC3’ 
5’GTAACCTTGCAATTTCCTCTCCAAATTTCTTC3’ 
ΔPxY GFP-
ALIX* 
5’GAAGAAATTTGGAGAGGAAATTGCAAGGTTAC3’ 
5’GTAACCTTGCAATTTCCTCTCCAAATTTCTTC3’ 
S718A GFP-
ALIX 
5’CATTGCCAGAGAACCTGCTGCTCCTTCAATTCCTACAC3’ 
5’GTGTAGGAATTGAAGGAGCAGCAGGTTCTCTGGCAATG3’ 
S721A GFP-
ALIX 
5’GAACCTAGTGCTCCTGCAATTCCTACACCTGC3’ 
5’-GCAGGTGTAGGAATTGCAGGAGCACTAGGTTC3’ 
S718A-S721A    
GFP-ALIX  
5’CATTGCCAGAGAACCTGCTGCTCCTGCAATTCCTACACCTG
3’ 
5’CAGGTGTAGGAATTGCAGGAGCAGCAGGTTCTCTGGCAAT
G3’ 
S712A-S729A 
GFP-ALIX  
WT to S712A: 
5’CTTAAAGGACTTGCAACAAGCCATTGCCAGAGAACCTAGTG
3’ 
5’CACTAGGTTCTCTGGCAATGGCTTGTTGCAAGTCCTTTAAG
3’ 
S712A to S712A-S729A: 
5’CTACACCTGCGTATCAGGCCTCACCAGCAGGAGGAC3’ 
5’GTCCTCCTGCTGGTGAGGCCTGATACGCAGGTGTAG3’ 
S718A-S721A 
ALIX-siRNA-
insensitive 
GFP-ALIX 
5’CATTGCCAGAGAACCTGCTGCTCCTGCAATTCCTACACCTG
3’ 
5’CAGGTGTAGGAATTGCAGGAGCAGCAGGTTCTCTGGCAAT
G3’ 
S712A-S729A 
ALIX-siRNA-
insensitive 
5’GAAGAAATTTGGGGAGGAGATCGCGAGATTACAGCATGCA
GCA3’ 
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GFP-ALIX 5’CTGCTGCATGCTGTAATCTCGCGATCTCCTCCCCAAATTTC
TTC3’ 
S718D-S721D 
GFP-ALIX 
5'GCATTGCCAGAGAACCTGATGCTCCTGATATTCCTACACCT
GCG3' 
5'CGCAGGTGTAGGAATATCAGGAGCATCAGGTTCTCTGGCAA
TGC3 
Y319F-I212D 
FLAG-ALIXBro1  
5’GAGATAAAATGAAAGATGCCGACATAGCTAAATTGGCTAAT
CAG3’ 
5’CCTGATTAGCCAATTTAGCTATGTCGGCATCTTTCATTTTAT
CTC3’ 
FLAG-ALIXV  5’GAGGAATTCGCGTGTCAGTACAGTCT3’ 
5’TGTTGCGGCCGCAGTCCTTTAAGAGTTCAT3’ 
638KMK640 to 
638EEA640 
mutation in 
ALIX  
5’CTCACATCAGGAATTTTCAGAAGCGGCGCAATCTAATAATG
AAG3’ 
5’GCTTCATTATTAGATTGCGCCGCTTCTGAAAATTCCTGATGT
GAG3’ 
 
643NNE645 to 
643YKK645
 
mutation in 
ALIX V 
domain 
5’CAGAAGCGGCGCAATCTTATAAGAAAGCTAACTTAAGAGAA
G3’ 
5’CTTCTCTTAAGTTAGCTTTCTTATAAGATTGCGCCGCTTCTG
3’ 
WT 
FLAG-ALG-2* 
5’GTGACTGTCAGGTCCATCATATCCATGTTTG3’ 
5’CAAACATGGATATGATGGACCTGACAGTCAC3’ 
E47A  
FLAG-ALG-2 
5’GAGTGATATCAGACACCGCGCTTCAGCAAGCTCTCTC3’ 
5’GAGAGAGCTTGCTGAAGCGCGGTGTCTGATATCACTC3’ 
E47A/E114A 
FLAG-ALG-2 
5’GATGATCGATAAGAACGCGCTGAAGCAGGCCCTCTCAG3’ 
5’CTGAGAGGGCCTGCTTCAGCGCGTTCTTATCGATCATC3’ 
E47A/E114A 
FLAG-ALG-2* 
5’GTGACTGTCAGGTCCATCATATCCATGTTTG3’ 
5’CAAACATGGATATGATGGACCTGACAGTCAC3’ 
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WT GST-ALG-
2  
5’TAAGAATTCCATGGCCGCCTACTCTTAC3’ (EcoR1) 
5’TAACTCGAGTCATACGATACTGAAGACCATG3’ (Xho1) 
E47A/E114A 
GST-ALG-2 
5’TAAGAATTCCATGGCCGCCTACTCTTAC3’ (EcoR1) 
5’TAACTCGAGTCATACGATACTGAAGACCATG3’ (Xho1) 
mCherry-
TSG101 
5’TAACTCGAGCT ATGGCGGTGTCGGAGAG3’ (Xho I) 
5’TAAGAATTCTCAGTAGAGGTCACTGAGACCG3’ (EcoRI) 
pCS2-MT-
ALIXnPRD 
5’TAAGAATTCATTAAAGGACTTGCAACAAAGCATTG3’ (EcoRI) 
5’TAACTCGAGTGGCGCAGCAGTCCC3’ (Xho I) 
pCS2-MT- 
S718A-S721A 
ALIXnPRD 
5’TAAGAATTCATTAAAGGACTTGCAACAAAGCATTG3’ (EcoRI) 
5’TAACTCGAGTGGCGCAGCAGTCCC3’ (Xho I) 
pCS2-MT- 
S712A-S729A 
ALIXnPRD 
5’TAAGAATTCATTAAAGGACTTGCAACAAGCCATTG3’ (EcoRI) 
5’TAACTCGAGTGGCGCAGCAGTCCC3’ (Xho I) 
pCS2-MT- 
S718D-S721D 
myc-ALIXnPRD 
5’TAAGAATTCATTAAAGGACTTGCAACAAAGCATTG3’ (EcoRI) 
5’TAACTCGAGTGGCGCAGCAGTCCC3’ (Xho I) 
pCS2-MT-
TSG101 
5’TAAGAATTCAATGGCGGTGTCGGAGAG3’   (EcoRI) 
5’TAACTCGAGTCAGTAGAGGTCACTGAGACCG3’  (Xho I)  
pCS2-HA-Plx1 
(Xenopus) 
5’AATGGGCCCTCAAGTGGCCGGTAAGAAAC3’ (Apa I) 
5’GCCTCTAGAGCCGAGGCCTTTACGTGTGC3’ (Xba I) 
pCS2-HA-Plx1 
K82R 
(Xenopus) 
5’AATGGGCCCTCAAGTGGCCGGTAAGAAAC3’ (Apa I) 
5’GCCTCTAGAGCCGAGGCCTTTACGTGTGC3’ (Xba I) 
pGEX-4T3- 
ALIXnPRD 
5’TAAGAATTCCTTAAAGGACTTGCAACAAAGCATTG3’ (EcoRI) 
5’TAACTCGAGTGGCGCAGCAGTCCC3’ (Xho I) 
pGEX-4T3- 
CHMP4b 
5’TAAGAATTCCATGTCGGTGTTCGGGAAG3’  (EcoRI) 
5’TAACTCGAGTTACATGGATCCAGCCCAG3’ (Xho I)   
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Protein extraction, immunoblotting and immunoprecipitation 
To prepare crude cell lysates for immunoblotting, cells scraped from culture 
plates or dishes were pelleted and extracted with cell lysis buffer consisting of 50 mM 
Tris-HCl, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5 mM EDTA, 100 µM sodium 
orthovanadate 100 µM sodium fluoride, 100 µM sodium pyrophosphate, 1 mM 
Dithiothreitol (DTT) and proteinase inhibitor cocktail (Sigma); 100-200 l of cell lysis 
buffer was used to extract cells from one 60-mm dish. Cell lysates were cleared by 
centrifugation at 16,000 g for 10 min at 4C.  
To prepare membrane solubilized cell lysates for immunoprecipitation, pelleted 
cells were extracted by sonication in 50-100 µl of cell lysis buffer that omits 0.1% SDS 
and includes 10 mM N-Ethylmaleimide (NEM) (Sigma) whenever indicated. Cell lysates 
were cleared by centrifugation at 16,000 g for 10 min at 4C and diluted 10 fold before 
immunoprecipitation.  
To prepare cytosolic proteins from asynchronously growing cells or mitotically 
arrested cells for immunoprecipitation or GST pull-down, pelleted cells were sonicated 
with 10 volumes of extraction buffer (EB), consisting of 80mM β-glycerophosphate, 20 
mM EGTA, 15 mM MgCl2, 150 mM NaCl, 1 mM DTT, and proteinase inhibitor cocktail 
(Sigma) (pH 7.4). For extraction of mitotically arrested cells and occasionally also 
asynchronously growing cells whenever indicated, EB was freshly supplemented with 1 
mM microcystin (Sigma) and 1 mM ATP (Sigma). Cell lysates were cleared by 
centrifugation at 16,000 g for 10 min at 4C. CIP (New England Biolabs) was added to 
MEE at a final concentration of 1 unit/mg substrate proteins according to the 
manufacture’s instruction.  
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To prepare cell lysates for dIP, pelleted cells were re-suspended with 10 
volumes of denaturing buffer consisting of 50mM Tris-HCl (pH 7.5), 1% SDS, and 5mM 
DTT, and sonicated. After the samples were boiled for 5 min and cleared by 
centrifugation at 16,000 g for 5 min, they were diluted 10-fold with an SDS neutralizing 
immunoprecipitation buffer consisting of 50 mM Tris-HCl (pH 7.5), 250 mM NaCl, 5 mM 
EDTA, 0.5% NP-40, 1 mM DTT (Tansey, 2007), and proteinase inhibitor cocktail 
(Sigma).  
The immunoprecipitation was performed by incubating indicated antibodies with 
the cell lysates by rotating at 4C overnight followed by adding Protein A or Protein G 
resin (Genscript) to the cell lysates and incubating by rotating at 4C for 1 h. The 
immnucomplex was washed five times with the same buffer used for 
immunoprecipitation. 
The protein samples were mixed with SDS sample buffer and boiled for 10 min 
before being subject to SDS-PAGE. The protein samples on the SDS-PAGE gel were 
then transferred onto nitrocellulose (NC) membrane, which was blocked by 5% non-fat 
milk in TBST (TBS (50 mM Tris-HCl, 150mM NaCl, PH7.4) plus 0.02% Tween 20) at 
room temperature for 1 h. Then, the NC membrane was incubated with primary 
antibodies diluted in 3% BSA in TBST at 4C overnight and HRP (horseradish 
peroxidase)-conjugated secondary antibodies diluted in 5% non-fat milk in TBST at 
room temperature for 2 h. The signal was detected by ECL (enhanced 
chemiluminescence) solution. Antibodies used in this study are summarized in Table 5. 
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Table 5. Antibodies used in this study 
Recognition Type Source 
Actin Mouse monoclonal Sigma-Aldrich. Cat#: A5441 
1A3 anti-ALIX Mouse monoclonal Made in our previous studies (Pan 
et al., 2006) 
1A12 anti-
ALIX 
Mouse monoclonal Made in our previous studies (Pan 
et al., 2006) 
1F7 anti-ALIX Mouse monoclonal Made in our previous studies (Pan 
et al., 2006) 
2H12 anti-
ALIX 
Mouse monoclonal Made in our previous studies (Pan 
et al., 2006) 
3A9 anti-ALIX Mouse monoclonal Made in our previous studies (Pan 
et al., 2006) 
ALG-2 Rabbit monoclonal Epitomics. Cat#: 3846-1 
Tubulin Rabbit monoclonal Cell Signaling. Cat#: 2125S 
CHMP4b Rabbit polyclonal  Santa Cruz. Cat#: sc-134946 
*CHMP4A Rabbit polyclonal Santa Cruz. Cat#: sc-67229 
*CHMP4B/C 
 
Rabbit polyclonal Abcam. Cat#: ab76334-100 
EIAV capsid 
antigen (CA) 
Mouse monoclonal A gift from Dr. Robert Mealey 
(Pullman, WA) (McGuire et al., 
1994; Mealey et al., 2009) 
 
EEA1 
 
Rabbit  
monoclonal 
Epitomics. Cat#: 3704-1 
EGFR Rabbit  
monoclonal 
Epitomics. Cat#: 1902-1 
ERK1 Rabbit polyclonal Santa Cruz. Cat#:sc-94 
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ERK2 Rabbit polyclonal Santa Cruz. Cat#:sc-154 
FLAG 
 
Mouse 
monoclonal 
Pierce  .Cat#: MA1-918781  
FLAG 
 
Rabbit  
polyclonal 
Sigma-Aldrich.Cat#: F7425-.2MG 
GFP Mouse  
monoclonal 
Santa Cruz. Cat#: sc-9996 
GST Rabbit  
polyclonal 
Santa Cruz. Cat#: sc-459 
HA  Rabbit  
polyclonal 
Santa Cruz. Cat#: sc-805 
HA Mouse  
monoclonal 
Pierce. Cat#: 26183 
IgG Mouse Sigma-Aldrich. Cat#: I5381-10MG 
IgG Rabbit Sigma-Aldrich. Cat#: I5006-10MG 
myc Rabbit polyclonal Santa Cruz. Cat#: sc-789 
MPM2 Mouse monoclonal Lab reserve 
#4381 
antibody 
Rabbit polyclonal Cell Signaling. Cat#: 4381 
pS2 antibody Rabbit polyclonal Made in this study 
p-ERK Mouse  
monoclonal 
Santa Cruz 
Cat#: sc7383 
p-Tyr Mouse monoclonal Cell Signaling. Cat#: 9416 
ubiquitin Mouse monoclonal Santa Cruz. Cat#: sc8017 
TSG101 Rabbit monoclonal  Epitomics. Cat#: 5377-1 
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Membrane floatation centrifugation 
The PNS of HEK293 cell lysates was prepared by re-suspending cell pellets in 
100 µl of 10% (w/v) sucrose in TE buffer (TBS plus 1 mM EDTA) supplemented with 
proteinase inhibitor cocktail. Cells were lysed by sonication followed by centrifugation at 
1800 g for 5 min at 4ºC. 0.1 ml of aliquot from each PNS was mixed with 0.4 ml of 85.5% 
(w/v) sucrose in TE buffer to generate a final concentration of 73% (w/v) sucrose. This 
73% (w/v) sucrose was placed at the bottom of a 4-ml ultracentrifuge tube, above 
which 2.3 ml of 65% (w/v) sucrose and 1.2 ml of 10% (w/v) sucrose in TE buffer were 
sequentially overlaid. The step sucrose gradients were ultracentrifuged at 100,000 g for 
18 h at 4ºC in a Beckman SW55-Ti rotor. After centrifugation, ten 0.4-ml fractions were 
collected by pipetting, and equivalent aliquots were taken from collected fractions for 
immunoblotting. In a typical execution of this protocol, fractions 3 and 4 contained 
membrane vesicles floating to the boundary of the 10% (w/v) and 65% (w/v) sucrose 
layers, whereas fractions 9 and 10 contained soluble proteins unable to float up. 
Proteinase K protection assay  
Mock treated or EGF stimulated cells were collected and pelleted by 
centrifugation at 1,800 g for 5 min. Pelleted cells were re-suspended in 10 volumes of 
6.5 µg/mL digitonin (Sigma) in PBS, followed by incubation first at room temperature for 
5 min and at 4ºC for 30 min. Samples were then centrifuged at 16,000 g at 4ºC for 5 
min, and pellets were re-suspended in 10 volumes of homogenization buffer containing 
100 mM K2HPO4/KH2PO4, 5 mM MgCl2 and 250 mM sucrose. Three aliquots with the 
same volume were taken equally from each sample, which were treated either with 
ddH2O, 4 ng proteinase K/µg sample protein or 4 ng proteinase K/µg sample protein 
plus 0.1% Triton X-100 at room temperature for 10 min. Proteinase K digestion was 
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stopped by adding SDS-PAGE sample buffer followed by being boiled for 10 min, and 
proteins were subject to SDS-PAGE and immunoblotting. Proteinase K should digest 
all EGFR in the presence of 0.1% Triton X-100, which solubilizes the membrane 
vesicles. Thus, the percentage of proteinase K-resistant EGFR in the absence of 0.1% 
Triton X-100 relative to total EGFR in ddH2O-treated sample was taken as the 
percentage of EGFR sorted into MVBs.  
GST pull-down 
GST and GST tagged proteins were produced and purified by the transformation 
of BL21 Competent E. coli stains (Thermo Fisher Scientific) with pGEX-4T3 based 
vectors for GST or GST tagged proteins. The transformed BL21 Competent E. coli 
stains were incubated with 0.1 mM IPTG (Sigma) to stimulate the expression of GST or 
GST tagged proteins. The E. coli stains were lysed with PBS containing lysozyme 
(Sigma), 1 mM DTT, proteinase inhibitor cocktail (PH 7.4) at 4ºC for 30 min. Then, 
Triton X-100 was added with the final concentration of 0.5%. The lysates were 
sonicated and cleared by centrifugation at 12,000 rpm at 4ºC for 40 min. The 
supernatant was incubated with Glutathione beads (GenScript) at 4ºC overnight. The 
beads were washed with buffer I, buffer II and buffer III, sequentially. The GST or GST 
tagged proteins were eluted by incubating the beads with elution buffer containing 50 
mM Tris-HCl, 150 mM NaCl, 1 mM DTT, proteinase inhibitor cocktail and 50 mM 
Glutathione (Sigma) at room temperature for 15 min. The elution step was repeated 
twice.   
For GST pull-down, the GTS or GST-tagged proteins, either untreated or treated, 
were first immobilized onto Glutathione beads by rotating at 4ºC for 2 h. The 
immobilized beads were then incubated with either cell lysates or in-vitro translated 
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proteins at 4ºC for 2 h. In vitro transcription and linked translation was performed by 
using the TNT QuickCoupled Transcription/Translation System (Promega) according to 
the manufacturer’s instruction. The beads were washed five times with the same buffer 
used during pull-down. The samples were then mixed with SDS-sample buffer and 
subject to SDS-PAGE.  
Biotinylation of cell surface proteins and affinity absorption of biotinylated 
proteins  
Serum-starved HEK293 cells cultured in 6-well plates were stimulated with 100 
ng/ml EGF for indicated lengths of time followed by rinse with ice-cold PBS (pH 7.4) 
supplemented with 1.5 mM MgCl2 and 0.2 mM CaCl2. The cells were then incubated 
twice (15 min each time) on a shaker with 200 mg/ml freshly prepared cold sulfo-NHS-
SS-biotin solution (0.75 ml/well) (bioWORLD) at 4°C, and quenched by wash with 
quenching solution (PBS supplemented with 1.5 mM MgCl2, 0.2 mM CaCl2 and 100 
mM glycine, pH 7.4) and further incubation in this solution at 4°C for 30 min. Cell 
lysates were prepared with cell lysis buffer consisting of 50 mM Tris-HCl, 150 mM NaCl, 
1% Triton X-100, 0.5 mM EDTA, 100 µM sodium orthovanadate, 100 µM sodium 
fluoride, 100 µM sodium pyrophosphate, 1 mM DTT and proteinase inhibitor cocktail 
and incubated with Streptavidin Separopore (Agarose) 4B (bioWORLD) at 4°C 
overnight. Pelleted beads were then washed five times with the same buffer used in 
incubation and proteins were eluted with SDS sample buffer for immunoblotting.  
In Vitro Phosphorylation of ALIX Fragments with Xenopus Extracts 
MEE and IOE were prepared in the previous studies in our laboratory (Wu et al., 
2010).  
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The in vitro phosphorylation reaction was performed by mixing one volume of 
substrate proteins and three volumes of IOE or MEE at room temperature for 2 h 
unless otherwise indicated, and terminated by adding SDS sample buffer. PLK1 
inhibitor BI-2536, PKD inhibitor CID755673, and pan-kinase inhibitor staurosporine 
were dissolved in DMSO and added to MEE at 4ºC 15 min prior to the phosphorylation 
reaction to reach a final concentration of 2 mM, 5 mM, and 5 mM, respectively.  
The EIAV VLP release assay  
HEK293 cells were transfected with pEV53B EIAV vector and cultured for 48 h. 
Conditioned medium was collected and loaded onto a 2-ml 20% sucrose cushion in a 
4-ml tube. After ultracentrifugation of the sample in an SW55-Ti rotor at 26,000 rpm for 
2 h, pelleted proteins were extracted by using SDS sample buffer and immunoblotted 
with anti-EIAV capsid antigen (CA) antibodies. 
Immunostaining and fluorescence microscopy 
Transfected HeLa cells were subcultured into chamber slides (Nunc Lab-Tek) 
coated with poly-D-Lysine (Cultrex) and cultured for 48 h before being fixed with 4% 
(w/v) of Paraformaldehyde at room temperature for 20 min. Fixed cells were 
permeabilized with 0.2% Triton X-100 in PBS followed by blocking with 1x blocking 
buffer (1% BSA, 0.25% horse serum, 0.2% Triton X-100 in PBS). Blocked cells were 
first stained with primary antibodies in 0.1x blocking buffer at 4ºC overnight, and then 
with Alexa Fluor 568, Alexa Fluor 488 or Alexa Fluor 647 conjugated secondary 
antibodies in TBST (0.1% Triton X-100 in TBS) at room temperature for 1 h. Nuclei 
were stained with DAPI (Sigma). Images were acquired using MetaMorph software 
(7.7.5.0) on ZEISS Axioplan2 image system (Objective: plan-NEOFLUAR 20×/0.50 or 
plan-NEOFLUAR 100×/1.30 oil).  
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Generation of rabbit polyclonal antibodies for phosphorylated ALIX at S718 and 
S721 
To prepare antigen, a synthetic phosphopeptide consisting of the residues 711 
to 724 of ALIX and phosphorylated at both S718 and S721 (CSIAREP(pS)AP(pS)IPT) 
was conjugated to keyhole limpet hemocyanin (KLH). To generate rabbit polyclonal 
antibodies, rabbits were immunized with the conjugated phosphopeptide for 42 days, 
and immunesera were collected. The IgG fraction of the antibodies was purified by 
protein G affinity chromatography. The phosphospecificity of the purified antibodies 
were evaluated with the enzyme-linked immune sorbent assay (ELISA). 
Statistical analysis 
Statistical analyses were performed using Student’s t-test. The p-value of ≥0.01 
and <0.05 was considered significant (*). The p-value of ≥ 0.001 and <0.01 was 
considered highly significant (**). The p-value of <0.001 was considered very highly 
significant (***). 
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